Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3028026	p-igm	g/l (g/l)	16994	30894	0.02%
3028026	s-igm	g/l (g/l)	6499	9592	0.04%
3028026	p-igm	— (—)	2356	3287	100.00%	Distribution not available
3028026	s-igm	— (—)	943	1407	100.00%	Distribution not available
3028026	igm	g/l (g/l)	7	7	0.00%	Distribution not available
3028026	s-immunoglobuliinim	g/l (g/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Kela reimbursement Agammaglobulinemia (D80-84)

247

163

68.94

320.28

5.4

1.6

0.98

1.55

g/l

1.29

212

154

Lymphoid leukaemia

569

1023

7.20

319.36

2.3

1.8

1.09

1.47

g/l

1.68

511

932

Asthma, hospital admissions , main diagnosis only

4072

19128

1.96

315.15

1.8

1.9

1.27

1.32

g/l

0.59

3768

17427

Cardiovascular diseases

3063

7566

2.27

314.74

1.8

1.25

1.33

g/l

1.64

2872

7019

Provisional assignment of new diseases of uncertain etiology

2768

12958

2.25

314.69

2.3

1.8

1.34

1.33

g/l

0.07

2563

11823

Codes for special purposes

2770

12976

2.25

314.38

2.3

1.8

1.34

1.33

g/l

0.07

2565

11839

Other heart diseases

2424

6743

2.47

313.58

1.9

1.8

1.26

1.36

g/l

1.26

2234

6234

Hypertensive diseases (excluding secondary)

2598

6551

2.42

312.29

1.7

1.8

1.20

1.38

g/l

4.55

2404

6042

Intestinal infectious diseases

4597

19215

1.88

310.51

2.0

1.8

1.26

1.32

g/l

0.94

4193

17562

Other acute lower respiratory infections

2748

12259

2.25

310.21

2.2

1.8

1.31

1.32

g/l

0.09

2514

11179

Osteopathies and chondropathies

2847

12612

2.22

308.13

2.3

1.8

1.28

1.33

g/l

0.55

2560

11495

Other soft tissue disorders, not elsewhere classified

4539

14376

1.92

308.08

1.9

1.25

1.31

g/l

1.15

4140

13153

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

214

111

82.37

308.05

12.5

1.3

14.75

1.16

g/l

33.25

206

101

Viral Sepsis

1328

3783

3.91

307.65

2.5

1.8

1.31

1.38

g/l

0.41

1227

3421

Tramadol

4208

11261

2.41

307.65

1.9

1.8

1.28

1.35

g/l

0.92

3836

10322

Asthma (diagnoses ohter than nonallergic)

4439

19043

2.02

307.65

1.8

1.9

1.26

1.33

g/l

1.27

4095

17355

Asthma

4239

8046

2.92

307.65

1.8

1.7

1.22

1.38

g/l

4.78

3921

7352

Sulfasalazine

1607

5107

3.40

307.65

1.7

1.23

1.35

g/l

1.90

1497

4597

Bacterial infection, other or unspecified

3965

10152

3.63

307.65

2.2

1.8

1.21

1.37

g/l

3.22

3648

9178

Purpura and other haemorrhagic conditions

1165

2773

4.99

307.65

2.2

1.9

1.24

1.37

g/l

0.95

1077

2527

Nonalcoholic fatty liver disease

1558

2029

11.77

307.65

1.5

1.9

1.20

1.32

g/l

1.38

1417

1873

Azathioprine

1470

2580

6.91

307.65

2.1

1.8

1.22

1.29

g/l

0.68

1379

2345

Dental caries

1734

5003

3.68

307.65

2.3

1.8

1.28

1.33

g/l

0.34

1586

4549

Abnormalities of breathing

4803

12728

2.30

307.65

1.8

1.23

1.33

g/l

2.21

4395

11640

Oxycodone

1977

6953

2.74

307.65

2.5

1.8

1.20

1.37

g/l

1.74

1773

6314

Asthma (only as main-diagnosis)

3899

8046

2.97

307.65

1.8

1.7

1.28

1.38

g/l

1.69

3611

7352

Acute upper respiratory infections

5004

16893

1.89

307.65

2.1

1.8

1.26

1.34

g/l

1.39

4580

15388

Autoimmune diseases excluding thyroid diseases

7547

12407

3.60

307.65

2.0

1.8

1.29

1.33

g/l

0.56

7035

11239

Covid-19 confirmed case

2105

8205

2.77

307.65

2.3

1.8

1.30

1.35

g/l

0.38

1942

7436

Certain disorders involving the immune mechanism

1636

4171

4.61

307.65

3.0

1.8

1.11

1.35

g/l

4.26

1506

3824

Chronic lower respiratory diseases

5834

17564

1.83

307.65

1.8

1.9

1.25

1.32

g/l

1.39

5383

16011

First line medication for Crohn's disease

8267

11957

4.08

307.65

2.1

1.6

1.23

1.38

g/l

5.40

7641

10845

Other diseases of intestines

5219

16054

1.92

307.65

1.9

1.8

1.28

1.31

g/l

0.44

4781

14717

All chronic kidney diseases

3196

9692

2.90

307.65

2.2

1.8

1.21

1.35

g/l

2.41

2933

8773

Any reimbursement code in KELA

3207

4759

3.57

307.65

2.0

1.4

1.24

1.36

g/l

2.46

2994

4345

5-aminosalicylic acid

1452

3771

4.28

307.65

2.0

1.8

1.26

1.33

g/l

0.72

1368

3428

Ascites

741

1251

7.45

307.65

1.6

1.9

1.44

1.53

g/l

0.38

687

1132

Implicit viral Sepsis

1733

5654

3.34

307.65

2.4

1.8

1.32

1.40

g/l

0.50

1594

5114

Certain infectious and parasitic diseases

3426

7967

2.23

307.65

1.9

1.7

1.30

1.31

g/l

0.13

3158

7265

Opioids

4794

12576

2.05

307.65

1.9

1.8

1.29

1.34

g/l

0.74

4408

11538

Non-Hodgkin lymphoma, all, including Hilmo

1302

2209

7.34

307.65

3.2

1.4

1.87

1.17

g/l

6.49

1232

1987

Inflammatory bowel disease treatment related agents

8738

13662

3.91

307.65

2.0

1.8

1.25

1.35

g/l

3.18

8102

12359

Asthma, unspecified (mode)

2822

7452

3.02

307.65

1.8

1.7

1.28

1.40

g/l

1.44

2600

6794

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

800

1323

7.68

307.65

3.2

1.8

2.39

1.45

g/l

4.79

732

1187

Reimbursement for rheumatic diseases

4548

12961

3.92

307.65

1.9

1.32

1.30

g/l

0.25

4252

11747

Other respiratory diseases principally affecting the interstitium

1268

3392

4.26

307.65

2.2

1.8

1.11

1.40

g/l

5.02

1177

3026

Liquid cancers, helper endpoint

4172

6420

6.96

307.65

3.5

1.5

1.95

1.14

g/l

21.62

3786

5828

Bacterial Sepsis

3046

8115

3.51

307.65

2.1

1.9

1.28

1.37

g/l

0.93

2769

7334

Multiple myeloma

512

351

28.99

307.65

4.9

1.3

0.50

1.14

g/l

7.73

410

315

ILD medications: azathioprine

1470

2308

7.75

307.65

2.1

1.6

1.22

1.35

g/l

1.47

1379

2106

Fever of other and unknown origin

4453

10126

4.36

307.65

2.3

1.8

1.31

1.33

g/l

0.15

4104

9193

L04AA Selective immunosuppressants

2342

5004

5.74

307.65

2.4

1.8

1.14

1.31

g/l

4.28

2223

4591

Abnormal serum enzyme levels

1957

6041

3.51

307.65

1.8

1.9

1.30

g/l

0.04

1838

5451

ILD differential diagnosis

3843

8130

2.47

307.65

1.9

1.7

1.29

1.38

g/l

1.22

3553

7427

Asthma, hospital admission 2, infections

3428

14012

2.55

307.65

2.0

1.9

1.26

1.32

g/l

0.71

3166

12737

Explicit Sepsis

2873

8520

3.45

307.65

2.2

1.9

1.24

1.37

g/l

2.07

2631

7713

Oedema, not elsewhere classified

1619

5752

2.96

307.65

1.9

1.8

1.28

1.38

g/l

0.99

1462

5170

Abnormal findings on diagnostic imaging of lung

2667

9928

2.77

307.65

2.0

1.9

1.30

1.36

g/l

0.52

2436

8927

Acute renal failure

1463

3997

4.12

307.65

2.2

1.8

1.31

1.38

g/l

0.40

1341

3569

All kidney diseases

5377

17125

2.25

307.65

2.1

1.8

1.25

1.33

g/l

1.63

4926

15649

Inflammatory bowel disease, strict (require KELA)

1633

5385

3.37

307.65

1.9

1.8

1.23

1.31

g/l

1.22

1537

4961

Heart failure, not strict

4186

11403

2.66

307.65

2.0

1.9

1.22

1.37

g/l

3.98

3843

10344

Rheumatoid arthritis

2069

5957

3.40

307.65

1.8

1.9

1.20

1.39

g/l

4.62

1915

5373

Infections, IBD-co-morbidities

1210

1416

6.87

307.65

2.1

1.9

1.30

1.40

g/l

0.52

1106

1292

Pain in joint

2951

8312

2.37

307.65

1.8

1.23

1.35

g/l

2.70

2690

7608

Influenza and pneumonia

6263

16770

2.52

307.65

2.2

1.7

1.24

1.32

g/l

1.87

5728

15366

All pneumoniae

6002

16926

2.51

307.65

2.2

1.7

1.24

1.32

g/l

1.89

5482

15504

Methotrexate

909

2284

4.45

307.65

1.9

1.8

1.19

1.38

g/l

2.31

830

2043

Secondary and unspecified malignant neoplasm of lymph nodes

738

1376

6.56

307.65

2.8

1.4

1.17

1.18

g/l

0.03

692

1246

Oral corticosteroids

8143

13166

4.03

307.65

1.9

1.8

1.24

1.36

g/l

3.78

7535

11896

GASTRO-related operations

4826

6571

3.92

307.65

1.9

1.6

1.30

1.31

g/l

0.13

4446

6037

Codeine

4477

12341

2.05

307.65

1.8

1.23

1.34

g/l

3.07

4096

11322

Budesonide

1055

2318

5.22

307.65

2.0

1.8

1.39

1.33

g/l

0.38

976

2096

Diseases of oesophagus, stomach and duodenum

5682

16272

2.19

307.65

1.9

1.33

1.30

g/l

0.34

5181

14878

Other pulmonary diagnosis

3878

8122

2.50

307.65

1.9

1.7

1.29

1.38

g/l

1.09

3585

7422

Disorders of gallbladder, biliary tract and pancreas

5164

15819

2.16

307.65

2.0

1.9

1.33

g/l

0.01

4747

14407

Other bacterial diseases

6052

15083

2.90

307.65

2.1

1.8

1.23

1.33

g/l

2.15

5551

13746

Dyspnoea

4641

16957

2.12

307.65

2.0

1.9

1.28

1.33

g/l

0.71

4265

15437

Headache

3123

11342

2.30

307.65

1.9

1.7

1.28

1.33

g/l

0.76

2889

10334

Other systemic involvement of connective tissue (FG)

1970

4708

4.69

307.65

1.9

1.38

1.42

g/l

0.30

1827

4225

Autoimmune diseases excluding thyroid diseases, strict definition

7344

12062

3.61

307.65

2.0

1.8

1.29

1.32

g/l

0.39

6846

10919

Noninfective enteritis and colitis

2966

11279

2.84

307.65

2.0

1.8

1.26

1.30

g/l

0.59

2770

10294

Autoimmune diseases

6760

12487

2.93

307.65

1.9

1.8

1.26

1.32

g/l

1.10

6268

11310

Bronchitis

5490

17864

2.02

307.65

2.1

1.8

1.30

1.32

g/l

0.16

5011

16307

Secondary uncertain malignant neoplasm

876

2171

4.57

307.65

2.7

1.4

1.21

1.16

g/l

0.23

814

1961

Chronic kidney disease

1930

5503

3.80

307.65

2.1

1.9

1.19

1.42

g/l

3.25

1761

4903

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1702

2568

3.47

307.65

1.8

1.7

1.27

1.28

g/l

0.04

1594

2341

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4001

13540

2.85

307.65

1.9

1.26

1.35

g/l

1.39

3664

12272

Asthma, unspecified (mode), excluding more controls

2775

6939

3.18

307.65

1.8

1.7

1.29

1.41

g/l

1.48

2558

6320

Gastrointestinal diseases

3079

5164

3.14

307.65

1.9

1.8

1.29

1.31

g/l

0.18

2847

4745

Other/unspecified seropositive rheumatoid arthritis

1598

5644

3.10

307.65

1.8

1.22

1.36

g/l

2.50

1483

5098

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1588

5549

3.14

307.65

1.9

1.8

1.22

1.35

g/l

2.31

1473

5015

Demyelinating diseases of the central nervous system

788

1753

5.43

307.65

3.5

1.7

1.08

1.39

g/l

4.06

773

1627

Cholangitis (primary sclerosing, PSC)

747

1084

9.28

307.65

2.7

1.8

1.28

1.44

g/l

0.86

710

979

Asthma, hospital admissions 3, pneumonia

2119

7898

2.89

307.65

2.1

1.9

1.24

1.33

g/l

0.97

1950

7112

Iron deficiency anaemia

2329

9316

2.63

307.65

1.9

1.32

1.38

g/l

0.68

2114

8430

Enlarged lymph nodes

1286

2814

5.27

307.65

2.4

1.8

1.26

1.37

g/l

0.60

1195

2541

Transplanted organ and tissue status

1100

1947

7.34

307.65

2.9

1.8

1.13

1.33

g/l

1.84

1034

1795

Malaise and fatigue

2636

8125

2.77

307.65

1.9

1.8

1.33

1.35

g/l

0.11

2391

7334

ILD medications: prednisolone, methylprednisolone, prednisone

8271

11795

4.30

307.65

2.0

1.6

1.24

1.39

g/l

5.43

7638

10673

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1056

880

10.21

307.65

2.2

2.0

1.13

1.44

g/l

2.13

986

790

General symptoms and signs

6175

12337

2.64

307.65

1.9

1.7

1.27

1.32

g/l

0.82

5711

11239

Implicit Sepsis

4179

13000

2.57

307.65

2.0

1.8

1.29

1.34

g/l

0.52

3803

11817

ILD, hospital admissions

1133

2829

4.65

307.65

2.2

1.9

1.13

1.41

g/l

4.15

1050

2523

Multiple myeloma and malignant plasma cell neoplasms

832

817

18.16

307.65

5.9

1.7

0.81

1.64

g/l

5.02

701

742

Oesophageal varices

596

766

11.90

307.65

1.7

1.9

1.56

1.38

g/l

0.81

550

700

L04AX Other immunosuppressants

4934

12828

4.40

307.65

2.4

1.7

1.12

1.35

g/l

13.46

4558

11719

Pneumonia, organism unspecified

5453

15482

2.63

307.65

2.2

1.7

1.24

1.32

g/l

1.70

4968

14166

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

899

692

24.19

307.65

4.6

1.3

3.28

1.15

g/l

18.18

802

629

Autoimmune diseases related-to ILD

6275

16667

3.53

307.65

2.0

1.8

1.24

1.35

g/l

3.44

5868

15075

Cirrhosis of liver, NAS

966

936

18.83

307.65

1.5

1.9

1.50

1.39

g/l

0.48

895

854

Cardiovascular diseases (excluding rheumatic etc)

3264

8657

2.27

307.65

1.8

1.24

1.34

g/l

2.18

3041

8012

Polyarthropathies

4448

10388

3.01

307.65

1.9

1.24

1.34

g/l

2.12

4105

9488

Anaemias

2001

2087

7.12

307.65

2.2

1.7

1.32

1.26

g/l

0.59

1860

1958

Condition for Implicit Sepsis (Organ dysfunction codes)

4430

14539

2.26

307.65

2.0

1.8

1.30

1.32

g/l

0.24

4022

13275

Finngen Rheumatological endpoints

5106

13413

2.27

307.65

1.8

1.9

1.29

1.33

g/l

0.59

4711

12235

ILD medications: immunosuppressive drugs

6520

10792

6.59

307.65

2.4

1.6

1.13

1.39

g/l

15.91

6072

9791

Excluding asthma or asthma-COPD overlap

3879

8122

2.50

307.65

1.9

1.7

1.30

1.38

g/l

1.02

3584

7422

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5784

16880

2.48

307.65

2.1

1.8

1.25

1.32

g/l

1.27

5279

15456

IBD patients in KELA-register

1633

5198

3.49

307.65

1.9

1.8

1.23

1.32

g/l

1.34

1537

4790

Seropositive rheumatoid arthritis

1620

4667

3.82

307.65

1.9

1.21

1.39

g/l

3.15

1504

4166

Interstitial lung disease endpoints

1143

2869

4.62

307.65

2.2

1.8

1.13

1.42

g/l

4.16

1059

2557

COPD/asthma related infections

5425

12097

2.35

307.65

2.0

1.7

1.26

1.34

g/l

1.47

4953

11061

Persons encountering health services for specific procedures and health care

5253

17413

1.87

307.65

2.0

1.8

1.22

1.32

g/l

2.64

4805

15938

Renal failure

2912

8234

3.43

307.65

2.1

1.9

1.24

1.39

g/l

1.96

2659

7393

ILD, hospital admissions 1, main diag only

1007

2569

4.55

307.65

2.2

1.9

1.10

1.40

g/l

4.64

937

2293

Caries of dentine

1540

4429

3.74

307.65

2.3

1.8

1.28

1.35

g/l

0.53

1402

4024

Coagulation defects, purpura and other haemorrhagic conditions

1472

4212

3.98

307.65

2.2

1.8

1.25

1.34

g/l

0.73

1364

3837

L04AD Calcineurin inhibitors

1146

2378

6.10

307.65

2.6

1.9

1.25

1.27

g/l

0.11

1089

2201

Asthma, excluding more controls

4143

7489

3.05

307.65

1.8

1.7

1.23

1.39

g/l

4.91

3839

6837

5487

12093

2.93

307.65

2.1

1.7

1.25

1.34

g/l

1.97

5013

11058

COPD differential diagnosis

3842

8133

2.47

307.65

1.9

1.7

1.29

1.38

g/l

1.22

3552

7430

Asthma (mode)

4094

8130

2.84

307.65

1.8

1.7

1.22

1.38

g/l

5.06

3791

7427

Implicit Sepsis

4397

14115

2.40

307.65

2.0

1.8

1.30

1.33

g/l

0.29

3992

12869

Other and unspecified anaemias

2963

8085

3.89

307.65

2.3

1.8

1.40

1.37

g/l

0.21

2676

7295

Asthma-related pneumonia or sepsis

2119

7898

2.89

307.65

2.1

1.9

1.24

1.33

g/l

0.97

1950

7112

Alcoholic liver disease

1054

1656

8.18

307.65

1.4

2.0

1.66

1.35

g/l

2.51

946

1505

Second line medication for Crohn's disease

5145

13154

4.48

307.65

2.4

1.7

1.13

1.35

g/l

12.72

4757

12019

COPD/asthma/ILD related infections

5425

12097

2.35

307.65

2.0

1.7

1.26

1.34

g/l

1.47

4953

11061

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7654

15026

3.88

307.65

2.2

1.7

1.30

1.31

g/l

0.17

7000

13727

Ulcerative colitis

1612

5530

3.20

307.65

2.0

1.8

1.24

1.32

g/l

1.01

1516

5075

Chronic hepatitis, not elsewhere classified

577

548

17.87

307.65

2.0

1.8

1.49

1.46

g/l

0.07

538

502

Certain infectious and parasitic diseases

5126

11163

2.41

307.65

2.0

1.7

1.28

1.32

g/l

0.40

4699

10218

Rheumatoid arthritis, including avohilmo

2257

8572

2.85

307.65

1.8

1.9

1.21

1.38

g/l

4.68

2085

7754

Metabolic disorders

4684

14790

2.01

307.65

1.9

1.19

1.36

g/l

5.61

4264

13559

Heart failure,strict

2500

7466

2.50

307.65

2.0

1.9

1.22

1.40

g/l

2.72

2294

6722

Implicit viral Sepsis

1325

3777

3.90

307.65

2.5

1.8

1.31

1.38

g/l

0.40

1225

3415

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4729

16709

1.91

307.65

2.0

1.8

1.23

1.34

g/l

2.95

4330

15287

Inflammatory bowel disease

2127

7421

3.14

307.65

1.9

1.8

1.26

1.31

g/l

0.71

1998

6798

MS-disease / Multiple Sclerosis

703

1460

5.91

307.65

3.5

1.7

1.02

1.40

g/l

7.40

691

1353

Hepatic failure, not elsewhere classified

454

577

11.03

307.65

1.8

1.9

1.50

1.38

g/l

0.35

425

528

Immunodeficiencies

786

922

13.92

307.65

4.2

1.7

1.07

1.37

g/l

1.88

714

851

Sicca syndrome [Sjögren]

753

1584

5.79

307.65

2.0

1.8

1.34

1.41

g/l

0.40

700

1436

Medical observation and evaluation for suspected diseases and conditions

3236

7376

2.34

307.65

1.9

1.30

1.29

g/l

0.06

2932

6729

Immunodeficiency with predominantly antibody defects

594

509

27.32

307.65

4.6

1.7

0.97

1.35

g/l

2.97

539

473

Examination and observation for other reasons

3200

7332

2.66

307.65

1.8

1.9

1.29

g/l

0.01

2972

6692

Nonhereditary hypogammaglobulinemia

277

214

41.22

307.65

5.0

1.6

1.02

1.50

g/l

1.26

243

199

Pneumonias (Asthma/COPD co-morbidities)

5988

16814

2.54

307.65

2.2

1.7

1.23

1.32

g/l

1.88

5468

15402

Other anaemias

2977

8162

3.85

307.65

2.3

1.8

1.40

1.37

g/l

0.18

2690

7366

Implicit bacterial Sepsis

2613

7093

3.58

307.65

2.1

1.9

1.26

1.40

g/l

1.63

2378

6384

Other and unspecified immunodeficiencies with predominantly antibody defects

318

255

38.90

307.65

5.1

1.6

0.81

1.46

g/l

3.55

297

238

Biological medication for rheuma

1380

3974

3.98

307.65

1.6

1.9

1.22

1.26

g/l

0.46

1309

3666

Cholangitis (primary sclerosing, PSC), with reimbursement 202

434

337

32.11

307.65

3.2

1.7

1.34

1.28

g/l

0.19

421

309

Diseases of liver

5041

6664

10.35

307.65

1.7

2.0

1.45

1.28

g/l

4.63

4598

6075

Dialysis, with operation codes

947

2412

4.55

307.65

2.4

1.8

1.19

1.36

g/l

1.18

880

2190

Aplastic and other anaemias

3205

8721

3.80

307.65

2.3

1.8

1.38

1.35

g/l

0.15

2893

7879

Thrombocytopenia, unspecified

729

1352

6.87

307.65

2.2

1.8

1.25

1.39

g/l

0.60

687

1229

Other arthritis (FG)

1747

6276

3.00

307.65

1.8

1.9

1.25

1.37

g/l

1.72

1629

5686

Colitis, primary sclerosing

336

271

31.84

307.65

3.4

1.5

1.28

1.31

g/l

0.07

328

252

ILD, hospital admissions 3, with pneumonia sepsis

699

1313

6.38

307.65

2.4

1.8

1.07

1.45

g/l

4.23

651

1178

Bacterial infection, other or unspecified

3731

9472

3.77

307.65

2.2

1.8

1.21

1.37

g/l

3.33

3426

8547

Seropositive rheumatoid arthritis, wide

1619

5707

3.11

307.65

1.9

1.8

1.21

1.35

g/l

2.53

1503

5154

Nutritional anaemias

2631

10731

2.51

307.65

1.9

1.35

1.36

g/l

0.08

2379

9704

Other systemic involvement of connective tissue

2032

5667

4.05

307.65

1.9

1.36

1.37

g/l

0.10

1881

5118

Symptoms and signs involving the digestive system and abdomen

4877

12637

2.00

307.65

1.9

1.26

1.31

g/l

0.63

4479

11521

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5487

12093

2.93

307.65

2.1

1.7

1.25

1.34

g/l

1.97

5013

11058

Other diseases of liver

2526

3303

10.62

307.65

1.6

1.9

1.29

1.28

g/l

0.10

2291

3043

Asthma (only as main-diagnosis), excluding more controls

3831

7489

3.10

307.65

1.8

1.7

1.27

1.39

g/l

2.26

3549

6837

2654

10525

2.68

307.65

2.0

1.8

1.22

1.32

g/l

1.59

2456

9619

ILD, hospital admission 2, with pulmonary infections

840

1398

7.25

307.65

2.3

1.7

1.06

1.40

g/l

4.24

782

1236

Other diseases of blood and blood-forming organs, wide

1834

4766

4.48

307.65

2.4

1.8

1.29

1.35

g/l

0.47

1685

4347

5763

14962

2.07

307.65

2.1

1.7

1.30

1.32

g/l

0.23

5267

13638

Non-follicular lymphoma

920

1776

6.50

307.65

3.2

1.8

1.65

1.28

g/l

1.88

868

1601

Other interstitial pulmonary diseases

1143

2859

4.63

307.65

2.2

1.9

1.13

1.43

g/l

4.22

1059

2547

Asthma-related pneumonia

2112

7879

2.88

307.65

2.1

1.9

1.24

1.33

g/l

0.98

1944

7094

Systemic connective tissue disorders

2827

7452

4.34

307.65

1.9

1.30

1.37

g/l

0.73

2621

6733

Renal tubulo-interstitial diseases

4787

16060

2.34

307.65

2.0

1.8

1.27

1.34

g/l

1.37

4374

14642

Other and unspecified iron deficiency

1871

7251

2.77

307.65

1.9

1.8

1.32

1.37

g/l

0.43

1694

6567

Interstitial lung disease

1143

2869

4.62

307.65

2.2

1.8

1.13

1.42

g/l

4.16

1059

2557

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1936

2790

9.61

307.65

1.5

2.0

1.54

1.34

g/l

2.45

1778

2543

Implicit bacterial Sepsis

2782

7704

3.40

307.65

2.0

1.9

1.26

1.38

g/l

1.57

2531

6940

Acute upper respiratory infections of multiple and unspecified sites

3800

14110

2.08

307.65

2.2

1.8

1.26

1.33

g/l

1.17

3487

12889

Any gastric operation

4826

6571

3.92

307.65

1.9

1.6

1.30

1.31

g/l

0.13

4446

6037

Other bacterial diseases

6247

15502

2.73

307.65

2.0

1.8

1.24

1.33

g/l

2.34

5759

14133

Other septicaemia

2450

6893

3.76

307.65

2.2

1.8

1.23

1.41

g/l

2.86

2250

6216

Condition for Implicit Sepsis (Organ dysfunction codes)

4589

15144

2.19

307.65

2.0

1.8

1.32

1.31

g/l

0.10

4180

13847

Other inflammatory liver diseases

742

1082

9.09

307.65

2.0

1.9

1.37

1.36

g/l

0.02

695

984

Abnormal findings on examination of blood, without diagnosis

3564

9429

3.90

307.65

2.2

1.8

1.53

1.29

g/l

4.41

3313

8542

Symptoms and signs involving the circulatory and respiratory systems

4860

12773

1.97

307.65

1.8

1.25

1.33

g/l

1.55

4493

11681

Used for control exclusion in common control thyroid runs

6241

11646

2.87

307.65

1.9

1.8

1.26

1.32

g/l

1.08

5792

10536

Fibrosis and cirrhosis of liver

1445

1244

21.15

307.65

1.8

2.0

1.84

1.38

g/l

5.15

1338

1135

Asthma-related infections

3428

14012

2.55

307.65

2.0

1.9

1.26

1.32

g/l

0.71

3166

12737

Multiple myeloma, including Hilmo

816

650

22.87

307.65

5.9

1.3

0.81

1.17

g/l

1.87

685

586

Septicaemia

2775

7675

3.72

307.65

2.2

1.8

1.24

1.39

g/l

2.38

2539

6934

Primary biliary cholangitis (PBC)

440

266

34.12

307.65

2.5

1.6

2.71

1.41

g/l

9.43

405

235

Tumor necrosis factor alpha inhibitors

1180

3560

3.76

307.65

1.6

1.9

1.23

1.27

g/l

0.44

1115

3291

ILD medications

8942

12043

4.43

307.65

2.1

1.6

1.22

1.39

g/l

7.22

8270

10907

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

512

351

28.99

307.65

4.9

1.3

0.50

1.14

g/l

7.73

410

315

Primary_lymphoid and hematopoietic malignant neoplasms

3084

4428

9.29

307.65

3.9

1.5

1.97

1.17

g/l

13.40

2815

3963

Other specified/unspecified arthritis

1542

5611

2.96

307.64

1.9

1.23

1.36

g/l

1.79

1438

5093

Gout

1443

4386

3.11

306.81

2.2

2.0

1.27

1.46

g/l

1.32

1323

3930

Bronchiectasis

661

1395

5.72

306.16

2.1

1.9

1.10

1.45

g/l

4.01

621

1242

Other diseases of pleura

2249

8513

2.46

304.60

2.0

1.9

1.27

1.37

g/l

0.89

2055

7671

Persons encountering health services in other circumstances, wide

5525

16224

1.81

304.55

1.9

1.8

1.27

1.32

g/l

0.70

5106

14737

Agranulocytosis

865

2262

4.47

302.94

2.8

1.8

1.15

1.38

g/l

2.19

810

2071

Mucosal proctocolitis

960

2688

4.07

302.39

2.1

1.8

1.25

1.31

g/l

0.38

903

2480

Acute sinusitis

2663

11505

2.25

301.09

2.3

1.7

1.27

1.32

g/l

0.59

2445

10560

Colitis, primary sclerosing, strict definition

263

210

33.72

301.01

3.4

1.5

1.23

1.21

g/l

0.05

257

195

Gastro-oesophageal reflux disease

3262

14132

2.08

298.98

1.9

1.33

1.31

g/l

0.18

2949

12892

Other special examinations and investigations of persons without complaint or reported diagnosis

3102

7377

2.21

296.17

1.8

1.9

1.26

1.29

g/l

0.30

2858

6729

Cough

2098

8480

2.47

294.62

1.9

1.13

1.35

g/l

8.25

1933

7709

Hernia of abdominal wall, postoperative

828

2091

4.25

294.42

1.8

1.6

1.39

1.45

g/l

0.19

751

1905

Heart failure and antihypertensive medication

1354

2881

3.31

293.60

2.0

2.1

1.18

1.48

g/l

3.99

1259

2607

Neurological diseases, wide definition

1503

2455

3.22

293.07

1.8

1.23

1.33

g/l

1.16

1410

2273

Other disorders of fluid, electrolyte and acid-base balance

1628

5916

2.81

292.41

1.9

2.0

1.30

1.47

g/l

1.79

1468

5333

Erysipelas

3201

12173

2.09

291.65

1.8

1.32

1.35

g/l

0.27

2916

11040

Pain in throat and chest

3895

12289

1.97

288.47

1.8

1.24

1.34

g/l

2.05

3549

11224

Diseases of the skin and subcutaneous tissue

4690

12984

1.87

285.40

1.9

1.8

1.28

1.30

g/l

0.18

4286

11850

Bacterial pneumoniae

1985

7361

2.51

284.16

2.2

1.8

1.21

1.37

g/l

2.02

1806

6680

Ulcerative colitis, NAS

992

2957

3.78

283.39

2.0

1.8

1.26

1.33

g/l

0.67

929

2726

Asthma, including avohilmo

5560

18363

1.75

281.63

1.8

1.9

1.27

1.32

g/l

0.77

5136

16727

Gout, FINNGEN

1443

5298

2.92

280.72

2.2

1.9

1.27

1.40

g/l

0.77

1323

4740

Chronic sinusitis

2247

10158

2.34

279.46

2.0

1.9

1.16

1.35

g/l

6.16

2060

9294

Codeine or tramadol medication

5277

16744

1.78

279.16

1.9

1.8

1.25

1.33

g/l

2.04

4817

15287

Intestinal infectious diseases

5370

17945

1.76

278.21

2.0

1.8

1.27

1.32

g/l

0.96

4898

16396

Bacterial pneumonia (organism specified)

2207

8937

2.36

277.42

2.2

1.8

1.20

1.35

g/l

2.29

2008

8074

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1116

3621

3.44

277.28

2.0

1.8

1.25

1.31

g/l

0.59

1053

3337

Crohn disease

948

2789

3.85

276.90

1.9

1.8

1.29

1.34

g/l

0.40

890

2561

Other specific joint derangements/joint disorders

3498

11697

2.01

276.37

1.8

1.9

1.24

1.33

g/l

1.83

3196

10722

Ulcerative colitis (strict definition, require KELA)

1137

3755

3.37

273.88

2.0

1.8

1.24

1.31

g/l

0.66

1070

3459

Nephropathy related operations

878

2483

4.07

273.74

2.4

1.9

1.16

1.32

g/l

1.08

817

2258

Abdominal and pelvic pain

4544

12637

1.86

273.72

1.9

1.25

1.31

g/l

0.83

4174

11521

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5146

16195

1.78

273.09

1.9

1.8

1.26

1.31

g/l

0.82

4782

14716

Hypertension, essential

3622

10678

1.99

272.33

1.7

2.0

1.19

1.38

g/l

6.45

3316

9811

Complications of surgical and medical care, not elsewhere classified

4621

18055

1.81

272.26

1.9

1.26

1.33

g/l

1.21

4219

16465

Non-Hodgkin lymphoma, all

402

591

8.58

272.20

3.7

1.3

2.62

1.14

g/l

5.13

375

540

Other necrotizing vasculopathies (FG)

504

927

6.59

272.03

2.0

1.9

0.98

1.44

g/l

4.16

470

825

Endocrine, nutritional and metabolic diseases

3799

10087

1.97

270.73

1.8

1.9

1.20

1.37

g/l

5.73

3512

9309

Viral hepatitis, IBD co-morbidity

412

613

7.73

270.46

1.4

1.9

1.62

1.32

g/l

2.60

383

561

Autoimmune hepatitis

204

122

43.45

269.81

2.3

1.5

1.50

1.59

g/l

0.10

199

111

Acute bronchitis

2092

9156

2.37

267.45

2.3

1.8

1.31

1.32

g/l

0.06

1904

8309

Neoplasms

3596

9889

1.99

267.33

2.1

1.5

1.34

1.18

g/l

3.09

3336

9109

Cholelithiasis, broad definition with cholecystitis

3950

14535

1.90

266.76

1.9

1.34

g/l

0.04

3599

13218

Diarrhoea and gastroenteritis of presumed infectious origin

3411

16326

1.96

266.45

2.0

1.8

1.26

1.32

g/l

0.74

3122

14926

Erysipelas

2459

10290

2.21

265.26

1.8

1.31

1.37

g/l

0.57

2220

9303

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1183

4087

3.20

262.85

2.0

1.8

1.24

1.29

g/l

0.51

1115

3766

Heart failure, strict

2635

8919

2.19

262.70

2.0

1.9

1.22

1.38

g/l

2.57

2411

8022

Other necrotizing vasculopathies

582

1256

5.57

262.43

2.0

1.9

1.09

1.42

g/l

1.85

543

1135

Undetermined asthma, excluding more controls

746

1912

4.28

262.15

2.1

1.6

1.16

1.44

g/l

3.46

691

1728

Osteoporosis

1381

4790

2.91

262.14

2.4

1.8

1.35

1.38

g/l

0.20

1233

4285

Glomerular diseases

1130

3816

3.28

261.58

2.4

1.9

1.18

1.35

g/l

1.54

1039

3477

Other disorders of white blood cells

515

1020

6.32

258.92

2.1

1.8

1.42

1.44

g/l

0.03

461

941

Seropositive rheumatoid arthritis, strict definition

988

3113

3.56

258.40

1.8

1.9

1.21

1.40

g/l

2.69

927

2821

Chronic lymphocytic leukaemia, helper endpoint

321

395

11.25

256.78

1.9

1.3

1.12

1.17

g/l

0.09

279

363

Chronic lymphocytic leukaemia

321

395

11.25

256.78

1.9

1.3

1.12

1.17

g/l

0.09

279

363

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

321

395

11.25

256.78

1.9

1.3

1.12

1.17

g/l

0.09

279

363

Diffuse large B-cell lymphoma, including Hilmo

422

702

7.64

255.00

3.3

1.4

1.15

1.16

g/l

0.02

400

637

Diffuse large B-cell lymphoma

422

702

7.64

255.00

3.3

1.4

1.15

1.16

g/l

0.02

400

637

Diffuse large B-cell lymphoma, helper endpoint

422

702

7.64

255.00

3.3

1.4

1.15

1.16

g/l

0.02

400

637

Hypothyroidism (congenital or acquired)

1211

2179

3.30

254.93

1.8

1.6

1.21

1.27

g/l

0.64

1118

2039

Bacterial pneumonia, not elsewhere classified

1844

6943

2.47

254.42

2.1

1.8

1.24

1.38

g/l

1.55

1679

6296

Diseases of the digestive system

2249

10511

2.24

254.26

1.8

1.9

1.28

1.35

g/l

0.83

2051

9543

Malignant immunoproliferative diseases

228

191

31.73

253.73

11.7

1.4

13.89

1.13

g/l

32.14

219

171

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2120

5880

2.38

253.48

1.9

1.8

1.26

1.42

g/l

3.55

1966

5417

Abnormal results of function studies

690

1749

4.61

252.16

1.8

1.9

1.23

1.37

g/l

1.24

624

1600

Cholelithiasis

3772

14297

1.88

251.47

1.9

1.35

1.34

g/l

0.08

3441

12997

Hypothyroidism and >3 levothyroxin purchases

1196

2160

3.29

250.73

1.8

1.6

1.21

1.27

g/l

0.72

1103

2020

Hypothyroidism, levothyroxine purchases

1196

2160

3.29

250.73

1.8

1.6

1.21

1.27

g/l

0.72

1103

2020

All-cause Heart Failure

2564

8765

2.17

249.65

2.0

1.9

1.21

1.38

g/l

2.84

2348

7877

Diarrhoea and gastroenteritis of presumed infectious origin

4669

18025

1.76

248.56

1.9

1.8

1.27

1.31

g/l

0.58

4278

16471

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

891

2686

3.68

248.50

2.6

1.5

1.18

1.20

g/l

0.10

833

2425

Undetermined asthma

746

1990

4.11

247.92

2.1

1.7

1.16

1.43

g/l

3.33

691

1806

Parasetamol

3493

9293

1.97

247.60

1.8

1.29

1.34

g/l

0.53

3229

8516

Other heart diseases, wide

4279

14905

1.81

247.28

1.8

1.27

1.31

g/l

0.61

3929

13655

Diseases of the respiratory system

2797

6781

2.14

246.78

1.9

1.7

1.33

1.38

g/l

0.46

2572

6182

Dermatitis

2933

15272

2.00

246.15

1.9

1.39

1.31

g/l

0.83

2680

13915

Depression medications

1366

2352

3.05

245.20

1.8

1.6

1.24

1.26

g/l

0.12

1274

2202

Pain, not elsewhere classified

1371

5261

2.77

244.75

1.9

1.8

1.26

1.35

g/l

0.77

1280

4775

Type 2 diabetes, wide definition

3567

12414

1.91

242.85

1.7

2.0

1.17

1.37

g/l

6.76

3242

11304

Other and unspecified dermatitis

2526

12630

2.10

241.65

2.0

1.9

1.39

1.31

g/l

0.82

2310

11522

Obesity related asthma

1791

7851

2.43

241.50

1.8

1.9

1.16

1.35

g/l

4.10

1655

7146

Nausea and vomiting

1383

5250

2.75

241.45

2.2

1.9

1.30

1.34

g/l

0.26

1278

4767

Hypertensive diseases

3614

11113

1.90

237.18

1.8

2.0

1.20

1.37

g/l

5.21

3311

10215

All influenza

1311

5012

2.80

236.85

2.7

1.7

1.22

1.35

g/l

1.12

1187

4570

Hypertension

3606

11105

1.90

235.39

1.8

2.0

1.20

1.37

g/l

5.19

3303

10208

Other disorders of skin and subcutaneous tissue

3193

15365

1.92

235.29

2.0

1.9

1.31

1.33

g/l

0.21

2904

13963

Pain in limb

3732

13940

1.85

235.07

1.9

1.27

1.32

g/l

0.69

3392

12749

Bleeding

3733

15000

1.83

229.59

1.9

1.36

1.29

g/l

0.79

3369

13675

Other noninfective gastroenteritis and colitis

1366

5429

2.70

228.84

2.1

1.8

1.25

1.32

g/l

0.53

1265

4945

Low back pain

3465

13801

1.87

226.13

1.9

1.8

1.29

1.34

g/l

0.46

3142

12631

Hypothyroidism, strict autoimmune

2879

9813

1.99

225.82

1.7

1.8

1.22

1.35

g/l

2.94

2595

8844

Mixed connective tissue disease

536

1234

5.24

223.96

2.0

1.8

1.46

1.44

g/l

0.07

509

1121

Other specified/unspecified systemic involvement of connective tissue

487

1040

5.66

222.78

1.9

1.8

1.47

1.41

g/l

0.22

459

942

Dermatitis and eczema

5000

18972

1.68

222.73

1.9

1.8

1.36

1.29

g/l

1.03

4579

17319

Other diseases of biliary tract

605

1519

4.57

222.59

2.3

1.9

1.25

1.41

g/l

1.03

563

1363

Implicit fungal Sepsis

506

1115

5.33

221.23

2.0

1.8

1.18

1.52

g/l

2.52

456

1002

Other gastritis (incl. Duodenitis)

1171

4400

2.86

219.73

1.9

1.39

1.36

g/l

0.13

1073

3964

Neurological diseases

3949

11325

1.80

215.48

1.9

1.8

1.28

1.32

g/l

0.54

3655

10384

SLE (Finngen)

314

454

8.64

215.48

2.0

1.7

1.32

1.49

g/l

0.55

289

407

Antihypertensive medication - note that there are other indications

2857

7830

2.00

214.98

1.7

1.9

1.25

1.35

g/l

1.81

2660

7209

Explicit bacterial Sepsis

663

1811

4.09

214.89

2.4

1.8

1.30

1.40

g/l

0.34

600

1634

6-mercaptopurine

330

509

8.10

213.50

2.0

1.7

1.21

1.30

g/l

0.36

310

470

Streptococcal septicaemia

567

1406

4.56

211.07

2.4

1.9

1.35

1.42

g/l

0.16

515

1266

General examination and investigation of persons without complaint and reported diagnosis

2753

7372

2.01

210.04

1.9

1.23

1.29

g/l

0.66

2540

6726

Other bacterial intestinal infections

1004

3571

3.05

209.92

2.0

1.8

1.20

1.38

g/l

1.68

902

3237

Haemorrhage from respiratory passages

1574

6173

2.42

209.67

2.1

1.9

1.52

1.37

g/l

1.05

1439

5571

Malignant neoplasm, wide definition for exclusion

3893

13258

1.78

208.55

2.4

1.6

1.44

1.22

g/l

3.98

3586

12142

Malignant neoplasm

3775

12867

1.79

208.48

2.4

1.6

1.45

1.22

g/l

4.01

3467

11785

Persons encountering health services in other circumstances

1952

9324

2.19

208.05

1.9

1.8

1.30

1.33

g/l

0.18

1811

8475

Glomerular disorders in diseases classified elsewhere

747

2267

3.71

207.68

2.5

1.9

1.14

1.37

g/l

1.75

684

2070

Asthma/COPD (KELA code 203)

4252

17523

1.71

207.18

1.8

1.9

1.25

1.32

g/l

1.16

3909

15975

Complications of medical and surgical care

3316

17407

1.82

206.11

1.9

1.25

1.35

g/l

1.67

3027

15851

Adalimumab

703

2075

3.86

205.20

1.5

1.9

1.23

1.27

g/l

0.40

660

1930

Pain (limb, back, neck, head abdominally)

3191

8677

1.90

204.08

1.9

1.8

1.26

1.34

g/l

1.01

2935

7929

Non-allergic asthma (mode), excluding more controls

883

2932

3.17

202.30

1.9

1.7

1.30

1.40

g/l

0.51

830

2652

Dorsalgia

4414

14252

1.71

201.62

1.8

1.29

1.33

g/l

0.58

4024

13043

Diseases of the musculoskeletal system and connective tissue

2449

6105

2.08

201.39

1.8

1.29

1.28

g/l

0.06

2274

5592

Arthropathies

4054

12068

1.75

200.41

1.8

1.9

1.27

1.32

g/l

0.77

3753

11059

Other nutritional deficiencies

3060

16251

1.84

199.44

1.7

1.9

1.17

1.33

g/l

8.24

2792

14906

Viral pneumonia

760

2378

3.51

199.30

3.0

1.7

1.38

1.36

g/l

0.09

692

2171

Fungal Sepsis

368

682

6.72

198.62

2.2

1.7

1.15

1.66

g/l

2.78

331

624

Implicit fungal Sepsis

349

634

6.93

192.82

2.2

1.7

1.16

1.63

g/l

2.35

314

582

Unspecified kidney failure

586

1584

4.11

192.60

2.2

1.9

1.12

1.50

g/l

2.88

533

1409

Complications of procedures, not elsewhere classified

3565

17429

1.75

192.35

1.9

1.26

1.34

g/l

1.54

3258

15883

Bacterial intestinal infections, IBD co-morbidities

1000

3721

2.91

192.09

2.0

1.8

1.22

1.35

g/l

0.94

899

3378

Early onset COPD, excluding more controls

890

3097

3.05

191.16

1.9

1.7

1.20

1.42

g/l

2.34

815

2801

Cardiac arrhythmias

2670

9293

1.93

190.58

1.8

1.9

1.28

1.38

g/l

1.47

2450

8548

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

125

113.30

188.99

14.4

1.4

14.59

1.08

g/l

19.37

120

Other medical care

2051

9279

2.08

188.96

2.3

1.9

1.25

1.37

g/l

1.47

1851

8372

Other Crohn's disease

532

1376

4.48

188.89

1.9

1.8

1.23

1.34

g/l

0.75

505

1279

Symptoms and signs involving the skin and subcutaneous tissue

3164

17938

1.79

188.76

2.1

1.8

1.35

1.32

g/l

0.30

2947

16313

Viral infections characterized by skin and mucous membrane lesions

2027

10234

2.08

188.73

2.5

1.8

1.34

1.32

g/l

0.07

1870

9365

Non-allergic asthma (mode)

883

3059

3.04

187.63

1.9

1.7

1.30

1.39

g/l

0.44

830

2776

Asthma and opportunity respiratory infection

398

835

5.88

187.07

2.1

1.8

1.05

1.53

g/l

3.79

375

751

Other bacterial intestinal infections

1178

4806

2.62

186.66

2.0

1.8

1.22

1.37

g/l

1.17

1063

4363

Cerebrovascular diseases (FINNGEN)

1375

4101

2.49

185.75

1.8

1.9

1.18

1.46

g/l

5.62

1265

3773

Ulcerative colitis (strict definition, all Crohn cases excluded)

875

3105

3.09

184.94

2.0

1.8

1.24

1.31

g/l

0.56

826

2863

Insulin medication

2675

12396

1.88

184.66

1.7

2.0

1.16

1.35

g/l

6.00

2423

11290

Other demyelinating diseases of the central nervous system

365

721

6.35

184.33

3.2

1.7

1.19

1.38

g/l

0.86

359

668

Persons encountering health services for examination and investigation

2751

7377

1.92

183.93

1.8

1.9

1.32

1.29

g/l

0.23

2537

6729

Atrial fibrillation and flutter

1361

3694

2.50

182.53

1.8

1.9

1.18

1.47

g/l

4.74

1255

3384

Disorders of mineral metabolism

556

1518

4.15

181.63

2.4

2.0

1.11

1.46

g/l

3.59

498

1380

Polyneuropathies and other disorders of the peripheral nervous system

1114

4496

2.67

181.57

2.5

1.8

1.54

1.34

g/l

1.37

1008

4064

Other (seronegative) rheumatoid arthritis, wide

1016

3944

2.79

179.84

1.8

1.9

1.22

1.38

g/l

2.25

931

3560

Other and unspecified disorders of white blood cells

367

745

6.14

179.55

2.2

1.8

1.56

1.45

g/l

0.20

325

692

Viral infections characterized by skin and mucous membrane lesions

3812

19980

1.68

179.40

2.2

1.8

1.36

1.30

g/l

0.65

3508

18247

Diseases of arteries, arterioles and capillaries (FINNGEN)

1066

2788

2.79

179.36

1.9

1.21

1.53

g/l

3.93

983

2549

Acute tubulo-interstitial nephritis

2643

12643

1.87

179.07

1.9

1.8

1.29

1.36

g/l

0.64

2388

11477

Disorders of thyroid, IBD co-morbidities

753

1635

3.40

178.87

1.8

1.9

1.23

1.45

g/l

2.11

689

1494

Infections of the skin and subcutaneous tissue

2681

14913

1.85

178.74

2.0

1.8

1.29

g/l

0.03

2458

13664

Rare circulating lymphoid malignancy, including Hilmo

289

471

7.87

178.62

3.0

1.4

0.87

1.15

g/l

2.11

262

436

Lower back pain or/and sciatica

4573

18933

1.62

178.53

1.8

1.9

1.28

1.32

g/l

0.70

4151

17310

Myeloid leukaemia

289

476

8.12

178.44

1.6

1.7

1.13

1.43

g/l

1.02

277

435

Other antidepressants

4481

14312

1.65

177.63

1.8

1.9

1.26

1.31

g/l

0.77

4063

13128

Vocal cord dysfunction

621

1607

3.69

177.04

2.1

1.8

1.26

1.41

g/l

0.90

568

1467

Alcohol use disorder, Swedish definition

2450

12290

1.90

175.73

1.5

1.9

1.41

1.29

g/l

2.13

2211

11275

Insulin, combination of fast acting with intermediate-acting or long-acting

2677

13789

1.84

173.76

1.7

1.9

1.17

1.35

g/l

5.71

2424

12557

Idiopathic thrombocytopenic purpura

308

554

7.21

173.18

2.3

1.6

1.28

1.49

g/l

0.56

283

511

Other and unspecified types of non-Hodgkin lymphoma, hilmo

358

733

6.02

173.01

3.4

1.8

1.76

1.55

g/l

0.43

343

665

Constipation

3853

16401

1.67

172.71

2.0

1.9

1.27

1.33

g/l

0.67

3482

15004

Enterocolitis due to Clostridium difficile

632

1934

3.62

172.33

2.0

1.8

1.23

1.40

g/l

0.86

569

1738

Disorders of other endocrine glands

2050

10542

2.00

172.02

2.0

1.8

1.22

1.33

g/l

1.72

1888

9622

Type 2 diabetes

4210

15368

1.64

170.66

1.6

2.0

1.20

1.35

g/l

5.44

3817

14052

Spondylopathies

3358

11837

1.75

170.60

1.8

1.9

1.19

1.35

g/l

4.51

3054

10794

Anxiety disorders, excluding more controls

3634

14320

1.70

170.57

1.9

1.30

1.29

g/l

0.09

3317

13156

2566

12985

1.85

170.03

1.6

1.9

1.41

1.29

g/l

2.02

2313

11919

Diabetes, varying definitions

4424

16433

1.62

169.43

1.7

1.9

1.20

1.34

g/l

4.82

4020

15049

Care involving dialysis

533

1491

4.07

168.58

2.2

1.9

1.06

1.37

g/l

2.45

492

1368

Diabetes mellitus

4436

16468

1.62

168.05

1.7

1.9

1.20

1.34

g/l

4.78

4033

15084

Noninfectious colitis NAS

786

2788

3.08

165.98

2.0

1.8

1.34

1.36

g/l

0.08

729

2539

Sleep apnoea

4038

16416

1.64

164.29

1.8

1.9

1.17

1.35

g/l

7.07

3651

15044

Other diseases of the digestive system

1438

6732

2.25

164.21

1.7

1.9

1.38

1.36

g/l

0.10

1316

6051

GI-bleeding

1431

6702

2.24

163.10

1.8

1.9

1.38

1.36

g/l

0.13

1308

6028

Idiopathic pulmonary fibrosis

481

1283

4.26

162.56

2.3

1.9

1.07

1.50

g/l

3.60

449

1144

Soft tissue disorders

4447

14570

1.61

162.04

1.7

1.9

1.24

1.31

g/l

1.41

4082

13328

2654

13388

1.81

162.02

1.6

1.9

1.40

1.29

g/l

1.83

2393

12289

Sleep apnoea, including avohilmo

4258

16799

1.61

161.55

1.8

1.9

1.17

1.35

g/l

7.21

3857

15384

Acquired haemolytic anaemia

262

434

8.08

161.00

2.7

1.6

1.72

1.53

g/l

0.37

241

398

Allergic asthma (mode), excluding more controls

1002

3944

2.60

160.63

1.7

1.21

1.35

g/l

1.97

932

3629

Selective deficiency of immunoglobulin G [IgG] subclasses

154

142

25.56

160.42

4.1

1.7

1.06

1.40

g/l

0.82

144

133

Other joint disorders

3720

12008

1.67

159.45

1.8

1.9

1.30

1.32

g/l

0.34

3407

11000

Seronegative rheumatoid arthritis

628

2005

3.42

159.03

1.8

1.9

1.14

1.40

g/l

3.45

583

1794

Diseases of the eye and adnexa

3570

10818

1.70

158.19

2.0

1.7

1.27

1.28

g/l

0.10

3304

9964

Unspecified jaundice

356

773

5.33

157.83

1.9

2.0

1.43

1.62

g/l

0.45

325

695

Systemic lupus erythematosus

314

622

6.23

157.51

2.0

1.8

1.32

1.36

g/l

0.13

289

571

Obesity and other hyperalimentation

2791

15844

1.76

156.48

1.6

1.9

1.16

1.34

g/l

9.45

2544

14541

Mood disorders, excluding more controls

4010

15143

1.62

155.11

1.8

1.9

1.29

1.30

g/l

0.14

3632

13895

Anxiety disorders

3922

17340

1.62

154.79

1.9

1.8

1.30

g/l

0.02

3581

15904

Obesity

2773

15790

1.75

154.58

1.6

1.9

1.16

1.34

g/l

9.31

2526

14491

Acute myeloid leukaemia and myelodysplastic syndromes

198

250

10.26

153.58

1.6

1.2

1.17

1.10

g/l

0.34

188

225

Neurotic, stress-related and somatoform disorders

3885

17244

1.62

153.50

1.9

1.8

1.30

g/l

0.00

3549

15817

Non-ischemic cardiomyopathy

1328

4904

2.30

153.12

2.2

1.9

1.34

1.44

g/l

0.65

1216

4374

Other and unspecified polyneuropathies, also in other diseases

950

3856

2.65

153.08

2.5

1.8

1.50

1.33

g/l

1.03

852

3467

Diagnoses used for exclusion with ILD

1218

5502

2.35

152.82

1.8

1.22

1.35

g/l

1.65

1110

4982

Diverticular disease of intestine

2901

10866

1.76

152.74

2.0

1.9

1.36

1.35

g/l

0.04

2640

9880

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

390

931

4.74

152.71

1.7

1.4

1.36

1.12

g/l

2.11

351

833

Other functional intestinal disorders

1955

9670

1.95

152.26

2.0

1.8

1.25

1.34

g/l

0.87

1775

8793

Heart failure and coronary heart disease

1749

6258

2.07

152.25

1.8

2.0

1.16

1.45

g/l

5.57

1604

5569

Episodal and paroxysmal disorders

4706

15656

1.56

152.09

1.8

1.9

1.27

1.33

g/l

1.21

4314

14326

Allergic asthma (mode)

1002

4051

2.53

151.77

1.7

1.21

1.34

g/l

1.87

932

3738

Pneumonia due to other infectious organisms, not elsewhere classified

285

534

6.54

151.55

2.6

1.7

1.08

1.44

g/l

2.04

259

492

Chronic rhinitis, nasopharyngitis and pharyngitis

1509

7429

2.13

151.13

1.8

1.15

1.36

g/l

6.08

1378

6799

Crohn's disease NAS

460

1255

4.19

151.13

2.0

1.8

1.27

1.36

g/l

0.44

432

1162

Nonalcoholic steatohepatitis

164

179

18.27

150.58

1.5

1.6

1.28

1.61

g/l

0.68

150

164

Other disorders of lacrimal gland

1618

8186

2.08

150.58

2.2

1.9

1.30

1.36

g/l

0.50

1477

7447

Mycoses

1297

6053

2.27

150.46

2.1

1.8

1.26

1.33

g/l

0.47

1171

5525

Hypo-osmolality and hyponatraemia

826

3133

2.80

150.19

1.9

1.25

1.45

g/l

1.63

752

2798

Symptoms and signs concerning food and fluid intake

554

1699

3.54

149.07

1.8

1.9

1.15

1.46

g/l

3.18

506

1528

Hypothyroidism, drug reimbursement

612

1320

3.45

148.56

1.9

1.7

1.32

1.33

g/l

0.03

558

1238

COPD (mode)

1123

3795

2.42

148.33

1.7

1.8

1.39

1.44

g/l

0.19

1012

3401

Toxic liver disease

195

258

10.82

148.14

1.5

1.8

1.23

1.60

g/l

0.67

186

239

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3982

15327

1.61

148.11

1.6

2.0

1.21

1.34

g/l

3.11

3619

14033

Irritable bowel syndrome

1291

6040

2.25

147.86

1.7

1.8

1.21

1.39

g/l

3.31

1164

5520

Benign neoplasm of colon, rectum, anus and anal canal

2597

13172

1.77

147.84

1.9

1.40

1.33

g/l

0.65

2376

11903

Gout, idiopatic and unspecified

1113

4915

2.40

147.60

1.6

1.9

1.16

1.40

g/l

2.15

1024

4404

Insulin, intermediate and long-acting

2328

12893

1.82

147.21

1.6

1.9

1.17

1.35

g/l

4.60

2109

11741

Cytomegalovirus infection, IBD co-morbidity

253

446

7.70

146.77

2.5

1.6

1.49

1.38

g/l

0.16

227

416

L04AC Interleukin inhibitors

449

1238

4.22

146.28

1.8

1.20

1.31

g/l

0.91

427

1150

Pleural effusion

756

2807

2.90

145.68

2.1

1.8

1.30

1.41

g/l

0.49

698

2501

Myelodysplastic syndrome, including Hilmo

238

388

7.49

145.59

2.2

1.3

1.54

1.15

g/l

0.99

217

350

Any event in cancer register

3866

14488

1.61

145.56

2.3

1.7

1.40

1.26

g/l

2.06

3540

13308

Depression

4097

18021

1.58

145.51

1.8

1.9

1.28

1.30

g/l

0.18

3718

16519

Other dorsopathies, not elsewhere classified

4235

14317

1.58

145.20

1.8

1.28

1.33

g/l

0.74

3893

13104

Atrial fibrillation and flutter with reimbursement

1040

2712

2.56

145.10

1.7

1.9

1.20

1.53

g/l

3.27

965

2466

Hard cardiovascular diseases

3503

13012

1.65

145.02

1.8

1.9

1.23

1.36

g/l

2.75

3236

11842

Haemolytic anaemias

311

658

5.84

144.99

2.6

1.7

1.63

1.40

g/l

0.73

286

605

Obesity due to excess calories

2120

11849

1.86

144.50

1.6

1.9

1.15

1.34

g/l

7.95

1932

10894

Care involving use of rehabilitation procedures

2693

14756

1.73

143.26

1.9

1.8

1.24

1.34

g/l

1.97

2479

13471

Cytomegaloviral disease

254

459

7.39

143.21

2.5

1.6

1.49

1.31

g/l

0.29

228

425

Hepatocellular carcinoma, including Hilmo

235

385

7.47

143.18

1.7

1.3

1.59

1.18

g/l

2.37

215

344

Chronic gastritis

1169

5326

2.31

142.89

1.8

1.9

1.29

1.37

g/l

0.63

1034

4773

Other disorders of urethra and urinary system

2929

12749

1.71

142.72

1.9

1.30

1.37

g/l

0.85

2670

11586

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2579

15073

1.75

142.41

1.9

1.24

1.34

g/l

1.69

2353

13718

Pneumocystosis

223

361

8.84

141.98

2.9

1.7

0.98

1.50

g/l

2.55

197

335

Common variable immunodeficiency

132

116

25.65

141.07

5.0

1.8

0.93

1.52

g/l

0.84

107

111

Valvular heart disease excluding rheumatic fever

1915

7396

1.94

141.03

2.1

1.9

1.28

1.34

g/l

0.50

1745

6689

SLE, strict definition

301

635

5.84

140.72

2.0

1.7

1.33

1.34

g/l

0.04

277

583

SLE, ICD10

301

635

5.84

140.72

2.0

1.7

1.33

1.34

g/l

0.04

277

583

Disorders of lipoprotein metabolism and other lipidaemias

3263

12473

1.66

140.72

1.7

1.9

1.14

1.37

g/l

7.42

2937

11391

Other autoimmune haemolytic anaemias

176

223

12.37

140.42

2.8

1.7

1.89

1.58

g/l

0.42

159

201

Non-rheumatic valve diseases

1898

7319

1.94

140.11

2.1

1.9

1.28

1.35

g/l

0.51

1730

6616

Heart failure and bmi 25plus

1467

4825

2.15

139.93

1.9

2.0

1.15

1.35

g/l

2.77

1330

4294

Gout, unspecified

933

3917

2.54

139.20

1.6

1.9

1.13

1.41

g/l

3.32

858

3489

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2256

10284

1.82

138.85

1.6

2.1

1.20

1.40

g/l

3.09

2018

9303

Presence of other functional implants

2327

9195

1.81

138.44

2.1

1.9

1.32

1.38

g/l

0.43

2076

8282

Spondyloarthritis

840

3359

2.65

138.37

1.7

1.8

1.29

1.37

g/l

0.72

791

3056

Mood disorders

4331

18580

1.54

138.22

1.8

1.9

1.29

1.30

g/l

0.19

3927

17004

Mood [affective] disorders

4322

18572

1.54

137.96

1.8

1.9

1.29

1.30

g/l

0.18

3918

17001

Type 2 diabetes, definitions combined

3879

14692

1.59

137.47

1.6

2.0

1.23

1.36

g/l

3.09

3517

13430

Non-invasive ventilation

981

3720

2.46

137.43

1.8

1.9

1.28

1.36

g/l

0.43

878

3436

Dorsopathies

4329

14442

1.56

137.27

1.8

1.26

1.33

g/l

1.31

3978

13224

Exposure to unspecified factor

4209

20088

1.54

136.79

1.9

1.8

1.27

1.31

g/l

0.57

3798

18411

Disorders of lacrimal system

1875

10245

1.90

136.61

2.1

1.8

1.32

1.35

g/l

0.20

1709

9303

Cholecystectomy

2934

15577

1.67

136.46

1.8

1.9

1.36

1.34

g/l

0.17

2687

14142

Marginal zone B-cell lymphoma, including Hilmo

184

251

10.30

135.89

3.0

1.4

2.67

1.12

g/l

3.06

177

228

Candidiasis

1339

6586

2.14

134.94

1.9

1.8

1.28

1.34

g/l

0.58

1215

6034

Type 2 diabetes, strict (exclude DM1)

3893

14824

1.58

134.82

1.6

2.0

1.24

1.36

g/l

2.48

3531

13553

Chronic hepatitis NAS

179

242

11.16

134.78

2.0

1.7

1.36

1.37

g/l

0.04

165

223

Ischemic heart diseases

3402

12887

1.63

134.01

1.9

1.26

1.35

g/l

1.16

3142

11713

Other immunodeficiencies

170

220

12.45

133.94

3.9

1.7

1.41

1.31

g/l

0.13

157

203

Factors influencing health status and contact with health services

1229

2734

2.33

133.78

1.9

1.7

1.31

1.29

g/l

0.09

1144

2505

Sleep disorders (combined)

4698

16590

1.52

133.78

1.7

1.9

1.22

1.34

g/l

3.31

4244

15191

Syncope and collapse

1658

7436

1.97

133.43

1.9

1.8

1.32

1.36

g/l

0.23

1505

6691

Disorders of calcium metabolism

404

1096

4.17

133.34

2.6

2.0

1.12

1.44

g/l

2.39

361

997

Percutaneous Coronary Intervention

3224

12337

1.65

133.14

1.8

1.9

1.21

1.36

g/l

2.81

2981

11203

Diabetes, insulin treatment (Kela reimbursement)

4166

16636

1.55

133.10

1.6

2.0

1.23

1.34

g/l

2.45

3783

15207

Other ulcerative colitis

404

1102

4.20

132.87

2.2

1.8

1.25

1.36

g/l

0.62

382

1014

Other viral diseases

1748

9377

1.93

132.69

2.1

1.8

1.39

1.26

g/l

1.36

1625

8697

Functional dyspepsia

1191

5638

2.22

132.40

1.9

1.8

1.39

1.33

g/l

0.33

1097

5133

Other diseases of urinary system

4154

15412

1.55

131.51

1.9

1.27

1.34

g/l

1.23

3795

14076

Continuous positive airway pressure

818

2740

2.65

130.83

1.9

2.0

1.22

1.38

g/l

1.20

726

2518

Other respiratory disorders and diseases

935

4037

2.46

130.62

2.1

1.8

1.27

1.35

g/l

0.34

842

3626

Other diseases of the respiratory system

935

4037

2.46

130.62

2.1

1.8

1.27

1.35

g/l

0.34

842

3626

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3936

16582

1.56

130.10

1.9

1.27

1.33

g/l

0.92

3602

15108

Gastroduodenal ulcer

1060

4811

2.30

129.44

1.8

1.9

1.25

1.39

g/l

1.00

970

4287

Other diseases of upper respiratory tract

4514

15808

1.52

129.05

1.9

1.22

1.34

g/l

3.76

4144

14408

Type 2 diabetes, definitions combined, including avohilmo

3877

14776

1.56

128.67

1.6

2.0

1.21

1.36

g/l

4.66

3509

13515

Abnormalities of heart beat

1445

7249

2.03

128.25

1.8

1.9

1.38

1.37

g/l

0.06

1295

6566

Urticaria and erythema

1666

8976

1.94

128.19

1.9

1.8

1.25

1.31

g/l

0.96

1531

8262

Acute pancreatitis

898

3841

2.48

128.13

2.0

1.8

1.29

1.34

g/l

0.25

833

3490

Respiratory disorders in diseases classified elsewhere

179

256

10.32

128.10

2.5

1.7

1.17

1.60

g/l

0.73

169

234

Symptoms and signs involving the urinary system

3122

15016

1.63

128.05

2.0

1.9

1.30

1.32

g/l

0.19

2805

13691

Coronary revascularization (ANGIO or CABG)

3202

12340

1.63

127.77

1.8

1.9

1.23

1.36

g/l

2.36

2960

11206

Etanercept

447

1342

3.79

127.36

1.6

1.9

1.27

1.34

g/l

0.43

418

1235

ILD-related respiratory insufficiency

265

547

5.93

126.83

2.4

1.8

1.08

1.57

g/l

2.12

241

493

Any death

2506

10741

1.73

126.60

2.0

1.9

1.31

1.32

g/l

0.07

2234

9769

Osteoporosis with pathological fracture (FG)

374

991

4.19

126.60

2.3

1.8

1.28

1.57

g/l

1.27

342

849

Other/unspecified cytomegaloviral diseases

218

385

7.76

126.57

2.7

1.6

1.44

1.40

g/l

0.05

198

354

Diabetes medication

4295

17111

1.52

126.49

1.6

1.9

1.21

1.34

g/l

4.20

3901

15657

Benign neoplasm: Colon

2172

12117

1.77

125.66

1.9

1.36

1.34

g/l

0.14

1986

10923

Drug-induced neutropenia

465

1445

3.66

125.58

2.7

1.9

1.09

1.42

g/l

2.79

444

1316

Crohn's disease of small intestine

449

1362

3.71

125.24

1.8

1.23

1.37

g/l

0.82

421

1267

Follicular lymphoma, hilmo

324

796

4.87

124.81

2.4

1.8

0.91

1.54

g/l

4.82

305

724

Systemic lupus erythematosus, unspecified

262

546

5.94

124.41

1.9

1.7

1.28

1.36

g/l

0.30

241

504

Emergency coronary revascularization (for ACS)

3417

13355

1.60

124.27

1.8

1.9

1.22

1.36

g/l

3.04

3157

12085

Polymyalgia rheumatica

624

2285

2.95

123.66

1.7

1.9

1.39

1.43

g/l

0.11

573

2026

Ulcer of lower limb, not elsewhere classified

690

2662

2.79

123.47

1.8

1.9

1.22

1.37

g/l

1.11

636

2386

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2164

12338

1.76

123.16

1.9

1.20

1.33

g/l

2.62

1982

11279

Depression or dysthymia

2850

9645

1.67

123.11

1.8

1.9

1.35

1.30

g/l

0.44

2588

8878

Adrenocortical insufficiency

293

673

5.24

123.04

2.3

1.7

1.22

1.42

g/l

0.50

277

618

Any mental disorder

4561

15506

1.50

122.92

1.8

1.9

1.30

g/l

0.04

4138

14232

Benign neoplasms

4063

14919

1.53

122.55

1.9

1.8

1.34

1.28

g/l

0.77

3709

13660

Gout, strict definition

819

3441

2.54

122.20

1.6

1.9

1.16

1.41

g/l

1.82

750

3064

Chronic apical periodontitis

4624

18057

1.49

122.05

1.9

1.8

1.30

1.31

g/l

0.15

4203

16512

Insulin, fast-acting

1574

8451

1.94

122.04

1.7

1.9

1.18

1.32

g/l

3.35

1440

7711

Use of hypnotics and sedatives

4372

17040

1.51

121.60

2.0

1.8

1.27

1.32

g/l

1.03

3977

15592

Substance abuse, excluding more controls

2303

11695

1.73

121.19

1.6

1.9

1.34

1.29

g/l

0.54

2083

10770

Extracorporeal dialysis

404

1178

3.94

120.79

2.3

1.9

1.00

1.36

g/l

3.41

371

1089

Other reaction to severe stress, and adjustment disorders

1633

8899

1.91

120.77

2.1

1.8

1.30

g/l

0.05

1527

8255

Major coronary heart disease event

3362

13097

1.59

120.07

1.8

1.9

1.24

1.36

g/l

2.00

3106

11880

Zoster [herpes zoster]

866

3758

2.46

120.07

2.7

1.8

1.49

1.39

g/l

0.36

782

3387

Other viral diseases

1387

7177

2.02

119.80

2.2

1.8

1.42

1.27

g/l

1.21

1281

6660

Crohn disease (strict definition, require KELA)

435

1334

3.69

119.66

1.8

1.18

1.36

g/l

1.70

410

1243

Crohn disease (strict definition, require KELA, min 2 HDR)

431

1315

3.71

119.56

1.8

1.18

1.30

g/l

1.25

407

1224

Pulmonary heart disease, diseases of pulmonary circulation

1335

6847

2.04

119.01

2.3

1.9

1.18

1.38

g/l

2.40

1255

6145

Disorders of eyelid, lacrimal system and orbit

3479

17382

1.56

118.73

2.1

1.8

1.30

1.33

g/l

0.24

3162

15850

Other/unspecified rheumatoid arthritis

633

2392

2.87

118.54

1.8

1.26

1.41

g/l

1.36

569

2144

Anxiety (asthma-related co-morbidities)

2566

12188

1.68

118.22

1.8

1.34

1.29

g/l

0.47

2337

11298

Other viral hepatitis

433

1340

3.66

117.49

1.4

1.9

1.60

1.28

g/l

3.14

406

1254

Dysphagia

1015

4732

2.25

117.03

2.0

1.9

1.33

1.42

g/l

0.42

932

4252

Failure and rejection of transplanted organs and tissues

170

254

9.65

116.67

2.8

1.5

1.14

1.30

g/l

0.42

163

236

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

450

1432

3.53

116.37

1.8

1.18

1.35

g/l

1.53

424

1334

Secondary hypertension

399

1148

3.73

116.29

2.0

1.10

1.54

g/l

3.09

363

1047

Iron deficiency anaemia secondary to blood loss (chronic)

748

3082

2.59

116.24

1.8

1.26

1.39

g/l

1.06

684

2782

Fibromyalgia

509

1736

3.20

115.50

1.8

1.25

1.39

g/l

0.85

460

1602

Respiratory insufficiency

377

1060

3.83

115.42

2.0

1.7

1.15

1.49

g/l

1.33

346

932

Benzodiazepine use

4103

19265

1.50

115.34

1.9

1.36

1.30

g/l

0.66

3720

17614

Disorders of lens

2665

10288

1.66

114.77

2.0

1.9

1.31

1.34

g/l

0.25

2430

9385

Myalgia

1075

5172

2.18

114.66

1.9

1.29

1.38

g/l

0.74

972

4742

Zoster [herpes zoster]

1996

11519

1.77

114.61

2.4

1.8

1.46

1.34

g/l

0.91

1816

10392

Other disorders of adrenal gland

333

885

4.39

114.48

2.2

1.8

1.24

1.37

g/l

0.34

314

806

Viral hepatitis

471

1558

3.38

114.03

1.5

1.8

1.60

1.29

g/l

3.24

441

1450

Wegener granulomatosis

174

272

8.76

113.55

2.4

1.6

0.76

1.28

g/l

3.59

166

250

Collagenous colitis

512

1785

3.16

112.37

2.1

1.8

1.29

1.42

g/l

0.51

471

1626

Other degenerative diseases of the nervous system

1169

4269

2.13

112.23

3.0

1.9

1.36

1.37

g/l

0.04

1093

3884

Cystitis

3443

13471

1.55

112.00

1.8

1.9

1.27

1.36

g/l

1.74

3156

12266

Abnormal findings on diagnostic imaging of other body structures

669

2691

2.67

110.08

1.9

1.16

1.37

g/l

2.74

622

2439

Glomerulonephritis

553

2032

2.98

110.01

2.2

1.9

1.27

1.37

g/l

0.41

513

1864

Genitourinary diseases

2445

7403

1.70

109.26

1.8

1.22

1.28

g/l

0.69

2270

6790

Nerve, nerve root and plexus disorders

4248

17996

1.48

108.78

1.9

1.34

1.32

g/l

0.18

3882

16408

Other disorders involving the immune mechanism, not elsewhere classified

261

606

5.23

108.53

3.1

1.7

1.13

1.30

g/l

0.75

239

562

Hypokalaemia

567

2115

2.88

108.29

1.9

1.8

1.32

1.43

g/l

0.63

507

1920

Insulin, fast-acting or short human

1578

8814

1.86

107.71

1.7

1.9

1.18

1.31

g/l

3.16

1444

8034

Protozoal diseases

255

588

5.36

107.51

2.8

1.8

1.02

1.45

g/l

2.92

227

545

Sarcoidosis

680

2796

2.62

107.15

1.8

1.17

1.34

g/l

1.90

632

2564

Crohn's disease of large intestine

345

988

3.97

105.59

1.9

1.8

1.22

1.43

g/l

1.36

322

913

All anxiety disorders

2607

13077

1.62

105.24

1.8

1.34

1.30

g/l

0.37

2374

12069

Other/unspecified dorsalgia

1539

8506

1.86

105.20

2.0

1.8

1.26

1.34

g/l

0.76

1405

7738

Symptoms and signs involving the nervous and musculoskeletal systems

2353

14711

1.65

105.17

1.9

1.29

1.33

g/l

0.37

2169

13395

Venous thromboembolism

2107

12367

1.70

105.12

2.2

1.9

1.22

1.36

g/l

2.16

1942

11164

Recurrent or chronic depression

1712

6810

1.82

104.65

1.8

1.29

1.30

g/l

0.10

1550

6305

Diseases of arteries, arterioles and capillaries

2539

11819

1.63

104.56

1.8

2.0

1.24

1.36

g/l

2.06

2317

10683

Pure hypercholesterolaemia

2756

11489

1.60

104.40

1.6

1.9

1.15

1.39

g/l

7.03

2477

10460

Spondylopathies (FG)

657

2687

2.60

103.74

1.6

1.9

1.28

1.35

g/l

0.43

624

2473

Cutaneous abscess, furuncle and carbuncle

1169

6024

2.03

103.29

1.8

1.27

1.32

g/l

0.30

1075

5550

Other (not insulin) diabetes medications

3829

15540

1.49

103.19

1.6

2.0

1.23

1.36

g/l

2.81

3469

14195

Migraine

2081

10194

1.70

103.16

1.8

1.27

1.33

g/l

0.90

1928

9383

Other CVD (FINNGEN)

478

1250

3.15

102.39

2.3

2.0

1.30

1.68

g/l

1.50

425

1119

Other headache syndromes

1741

10134

1.77

102.33

1.8

1.9

1.26

1.36

g/l

1.20

1600

9271

Candidiasis

682

2869

2.55

101.99

2.1

1.8

1.23

1.38

g/l

1.42

614

2621

Ulcerative ileocolitis

291

763

4.41

101.72

2.2

1.8

1.25

1.37

g/l

0.66

278

709

Hyperkalaemia

321

893

4.00

101.63

2.1

1.9

1.36

1.52

g/l

0.38

293

802

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

270

665

4.54

101.39

1.6

1.3

1.39

1.14

g/l

1.48

239

599

Acute pancreatitis (for exclusion)

898

4237

2.24

101.37

2.0

1.8

1.29

1.32

g/l

0.13

833

3856

Polyarthrosis

840

3561

2.30

100.97

1.8

1.9

1.24

1.40

g/l

1.06

755

3189

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2300

14438

1.64

100.73

1.8

1.9

1.25

1.34

g/l

1.29

2090

13147

Psoriatic and enteropathic arthropathies

564

2180

2.77

100.46

1.6

1.9

1.24

1.33

g/l

0.54

516

1998

Intracranial trauma

2255

9764

1.66

100.42

1.8

1.29

1.32

g/l

0.23

2050

8984

Any operation in hilmo

158

11.35

100.24

1.5

1.2

1.28

1.30

g/l

0.04

143

Visual disturbances and blindness

2098

12912

1.68

100.15

2.0

1.9

1.30

1.33

g/l

0.24

1904

11750

Eosinophilic disease (BM)

149

223

8.58

99.93

1.8

1.6

1.08

1.38

g/l

1.10

137

206

DVT of lower extremities and pulmonary embolism

1623

9356

1.79

97.76

2.3

1.9

1.20

1.38

g/l

2.30

1494

8443

Systemic sclerosis (FG)

184

347

6.39

96.96

1.8

1.9

1.43

1.48

g/l

0.12

168

313

Hyperlipidaemia, other/unspecified

1444

7430

1.85

96.78

2.0

1.20

1.44

g/l

2.63

1296

6725

Other symptoms and signs involving the digestive system and abdomen

726

3196

2.39

96.72

2.1

1.8

1.36

1.38

g/l

0.11

651

2899

Drug-induced adrenocortical insufficiency

185

360

6.74

96.32

2.4

1.7

1.06

1.36

g/l

1.84

176

335

Follow-up examination after treatment for conditions other than malignant neoplasms

1632

6151

1.80

95.79

1.7

1.9

1.30

1.31

g/l

0.12

1488

5600

Asthma and allergy, excluding more controls

556

2141

2.69

95.68

1.8

1.7

1.20

1.32

g/l

1.29

515

1988

Diaphragmatic hernia

1444

8160

1.84

95.07

1.9

1.39

1.36

g/l

0.18

1296

7366

Disorders of parathyroid gland

864

4060

2.21

95.00

2.0

1.8

1.21

1.40

g/l

2.28

778

3633

Other disorders of skin and subcutaneous tissue, not elsewhere classified

667

2863

2.48

94.97

2.1

1.9

1.29

1.36

g/l

0.28

594

2593

COPD

1645

7813

1.78

94.59

1.8

2.0

1.34

1.37

g/l

0.17

1494

7016

Chronic pancreatitis

577

2325

2.66

94.58

1.6

1.9

1.17

1.34

g/l

1.63

532

2112

Disturbances of skin sensation

1201

6435

1.95

94.26

2.1

1.8

1.37

1.31

g/l

0.31

1111

5918

Use of glatiramer acetate

169

307

7.09

94.17

3.7

1.7

0.99

1.21

g/l

2.91

163

287

Urticaria

1313

7237

1.89

94.14

1.9

1.8

1.28

1.31

g/l

0.28

1205

6669

Other anxiety disorders

1936

10222

1.69

94.05

1.8

1.34

1.29

g/l

0.55

1756

9462

Asthma and allergy

556

2170

2.66

93.08

1.8

1.7

1.20

1.31

g/l

1.13

515

2014

Amyloidosis

179

343

6.37

93.05

3.7

1.8

1.24

1.65

g/l

0.74

169

311

Other intervertebral disc disorders

3177

12890

1.51

92.47

1.8

1.9

1.29

1.34

g/l

0.64

2897

11774

Other diseases of pancreas

422

1474

3.14

92.15

1.8

2.0

1.26

1.43

g/l

0.73

385

1341

Symptoms and signs involving cognition, perception, emotional state and behaviour

3818

18275

1.45

92.04

1.8

1.9

1.31

g/l

0.01

3463

16711

Visual disturbances

1949

12039

1.67

92.01

2.0

1.9

1.31

1.33

g/l

0.19

1782

10969

Gastric ulcer

707

3143

2.36

91.84

1.8

1.26

1.35

g/l

0.42

646

2798

Other diseases of intestine

635

2709

2.49

91.44

2.0

1.8

1.29

1.43

g/l

0.84

593

2442

Pulmonary embolism

1169

6271

1.94

91.13

2.3

1.8

1.16

1.36

g/l

2.36

1096

5629

Mental and behavioural disorders due to psychoactive substance use

2376

14236

1.59

90.81

1.6

1.9

1.34

1.29

g/l

0.61

2148

13060

Other diseases of pericardium

275

747

4.16

90.76

2.3

1.9

1.16

1.43

g/l

1.37

249

681

Concussion

1928

9635

1.67

90.28

1.8

1.26

1.32

g/l

0.66

1764

8869

All influenza (not pneumonia)

663

2897

2.42

90.07

2.4

1.7

1.29

1.36

g/l

0.31

603

2662

Mycoses

3378

20400

1.47

90.03

1.9

1.30

1.31

g/l

0.09

3068

18664

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

233

573

4.88

89.89

3.0

1.7

1.07

1.32

g/l

1.42

214

533

Spondylosis

2040

10355

1.65

89.77

1.8

1.9

1.19

1.37

g/l

2.81

1860

9424

Pulmonary heart disease

1169

6304

1.93

89.66

2.3

1.8

1.16

1.36

g/l

2.43

1096

5660

Substance abuse

2303

13955

1.59

89.32

1.6

1.9

1.34

1.29

g/l

0.48

2083

12798

Disorders of sclera, cornea, iris and ciliary body

2184

13957

1.61

89.19

1.9

1.25

1.31

g/l

0.95

2024

12743

Hereditary hypogammaglobulinemia

28.80

88.74

4.4

1.5

0.86

1.18

g/l

1.85

Hodgkin lymphoma, hilmo

229

563

4.87

88.32

2.2

1.7

0.98

1.46

g/l

2.40

215

516

Psychiatric diseases

3967

14009

1.44

87.84

1.8

1.9

1.29

g/l

0.07

3617

12868

Diseases of the ear and mastoid process

4666

16994

1.40

87.72

1.9

1.8

1.32

1.29

g/l

0.27

4239

15587

Marginal zone B-cell lymphoma

111

141

11.49

87.52

2.5

1.4

2.10

1.23

g/l

1.68

106

130

Sciatica+with lumbago

1973

11336

1.64

87.43

1.8

1.9

1.23

1.35

g/l

1.66

1816

10354

Other diseases of anus and rectum

1156

6241

1.92

87.36

1.9

1.34

1.39

g/l

0.25

1035

5635

Senile cataract

2312

9039

1.61

87.24

2.0

1.9

1.35

1.34

g/l

0.05

2091

8215

Persons with potential health hazards related to communicable diseases

1624

9623

1.73

87.10

2.3

1.8

1.24

1.27

g/l

0.23

1531

8926

Ulcerative rectosigmoiditis

444

1646

2.94

86.67

1.8

1.22

1.33

g/l

0.77

416

1519

Herpesviral [herpes simplex] infections

578

2434

2.55

86.35

2.3

1.9

1.16

1.40

g/l

2.81

538

2230

Disorders of optic nerve and visual pathways

501

1978

2.75

86.31

2.9

1.8

1.06

1.40

g/l

5.90

474

1822

Unspecified acute lower respiratory infection

684

3088

2.34

86.31

2.3

1.8

1.31

1.33

g/l

0.08

632

2834

Convulsions, not elsewhere classified

888

4349

2.09

86.31

1.7

1.8

1.28

1.32

g/l

0.30

812

3955

Other pleural conditions

464

1759

2.83

86.06

2.2

1.9

1.29

1.38

g/l

0.32

425

1566

Papulosquamous disorders

1585

9479

1.73

85.20

1.7

1.9

1.25

1.33

g/l

0.84

1446

8658

Malignant neoplasm of liver and intrahepatic bile ducts

180

371

5.59

85.00

1.6

1.3

1.45

1.16

g/l

1.60

157

336

Exclusions for E4_PCOS_BROAD

824

4031

2.16

84.87

2.0

1.9

1.21

1.34

g/l

1.01

773

3740

Hypercalcemia

280

811

3.97

84.83

2.7

1.8

1.02

1.47

g/l

3.32

250

733

STROKE

2072

8863

1.63

84.57

1.8

2.0

1.28

1.41

g/l

1.65

1889

8045

Other chronic obstructive pulmonary disease

1551

7545

1.75

84.38

1.8

2.0

1.36

1.37

g/l

0.08

1400

6761

Hepatomegaly and splenomegaly, not elsewhere classified

117

166

9.83

83.59

2.1

1.9

1.30

1.32

g/l

0.03

108

153

Volume depletion

420

1533

2.93

83.50

1.9

1.23

1.47

g/l

1.17

384

1372

Drug-induced osteoporosis with pathological fracture

159

307

6.77

83.47

2.5

1.9

1.09

1.23

g/l

0.51

150

278

Hypothyreosis and Thyroxine purchase for inclusion criteria

3577

16569

1.44

83.15

1.7

1.9

1.23

1.34

g/l

3.14

3237

15142

Crohn disease (strict definition, all UC cases excluded)

315

992

3.55

82.93

1.6

1.8

1.12

1.34

g/l

1.60

292

918

Other general symptoms and signs

281

809

3.78

82.86

1.8

1.7

1.49

1.37

g/l

0.22

260

744

Mantle cell lymphoma, including Hilmo

128

200

8.21

82.57

2.9

1.3

0.95

1.09

g/l

0.44

117

185

Other overlap syndromes

159

307

6.47

82.53

2.1

1.7

1.34

1.36

g/l

0.05

153

283

COPD, hospital admission 2, with asthma infections

1196

5667

1.88

82.49

1.9

1.37

g/l

0.00

1072

5066

Amyloidosis, other/unspecified

156

297

6.55

82.17

4.0

1.8

1.29

1.68

g/l

0.57

146

270

FESS (DNB20)

612

2702

2.42

82.12

1.9

1.18

1.39

g/l

2.27

563

2489

Ethmoidectomy

629

2811

2.39

81.97

1.9

1.18

1.37

g/l

2.16

579

2589

Hypothyroidism, other/unspecified

3454

15982

1.45

81.96

1.7

1.9

1.23

1.35

g/l

3.44

3128

14605

Fall on same level

4570

18296

1.39

81.93

1.8

1.9

1.25

1.31

g/l

1.12

4144

16816

Infection due to other mycobacteria

133

219

7.51

81.00

1.8

1.6

1.40

1.74

g/l

0.43

121

197

Systemic sclerosis

184

408

5.40

80.70

1.8

1.7

1.43

1.31

g/l

0.41

168

371

Other abnormalities of plasma proteins

143

257

7.09

80.40

3.2

1.7

1.48

1.27

g/l

0.31

134

233

Disorders of the thyroid gland

3657

16982

1.43

80.22

1.7

1.9

1.22

1.34

g/l

3.80

3324

15520

Defects in the complement system

104

139

11.86

79.75

3.4

1.7

1.57

1.33

g/l

0.24

132

Optic neuritis

275

821

3.80

79.20

3.4

1.7

1.07

1.37

g/l

3.42

268

766

Biguanides

3633

15781

1.43

79.04

1.6

2.0

1.23

1.35

g/l

2.39

3285

14422

Other arrhythmias

2360

11793

1.54

78.01

1.9

1.8

1.30

1.34

g/l

0.35

2165

10765

Viral pneumonia (unknown virus, not influenza)

378

1364

3.03

77.94

3.1

1.9

1.38

1.42

g/l

0.10

348

1258

Other infectious diseases

444

1743

2.75

77.15

1.9

1.15

1.39

g/l

1.94

403

1585

Hepatocellular carcinoma

148

281

6.21

77.10

1.5

1.3

1.66

1.16

g/l

1.80

133

253

Vasculitis limited to skin, not elsewhere classified

195

470

4.91

76.94

2.1

1.7

1.23

1.50

g/l

0.80

178

430

Anaemia in chronic diseases classified elsewhere

176

392

5.35

76.72

1.8

1.7

0.98

1.47

g/l

1.71

156

363

Other symptoms and signs involving the nervous and musculoskeletal systems

1663

10346

1.66

76.31

2.0

1.9

1.28

1.32

g/l

0.38

1552

9440

Selective serotonin reuptake inhibitors

3843

14447

1.41

76.14

1.7

1.9

1.30

1.31

g/l

0.04

3474

13259

Fibrosis of liver

102

141

11.45

76.07

1.6

1.7

1.31

1.36

g/l

0.07

129

Psoriasis

1169

6641

1.83

75.93

1.6

1.9

1.27

1.34

g/l

0.52

1068

6089

Solid cancers, helper endpoint

3077

12648

1.46

75.71

2.0

1.6

1.30

1.22

g/l

0.97

2822

11580

Chronic ulcer of skin, not elsewhere classified

345

1205

3.12

75.30

1.9

1.8

1.21

1.42

g/l

1.00

316

1085

Rheumatism, unspecified

605

2766

2.31

74.17

1.8

1.9

1.24

1.41

g/l

1.20

551

2520

602

2745

2.31

74.12

2.1

1.8

1.25

1.34

g/l

0.52

547

2506

Sequelae of external causes of morbidity and mortality

1038

5740

1.88

73.87

2.1

1.9

1.26

1.36

g/l

0.67

950

5213

Paroxysmal tachycardia

808

3394

2.06

73.83

1.8

1.9

1.28

1.44

g/l

0.86

746

3121

Ulcerative enterocolitis

214

567

4.34

73.75

2.2

1.7

1.21

1.33

g/l

0.56

196

522

Disorders of skin appendages

1905

12336

1.58

73.12

1.9

1.8

1.31

1.30

g/l

0.04

1748

11311

Vasomotor and allergic rhinitis

1497

8988

1.68

73.11

1.8

1.22

1.33

g/l

1.77

1371

8283

Other and unspecified vasculitis limited to skin

180

426

5.03

72.83

2.1

1.6

1.24

1.31

g/l

0.19

165

391

Falls/tendency to fall

4311

15958

1.37

72.21

1.8

1.9

1.25

1.31

g/l

1.09

3957

14665

Giant cell arteritis

239

692

3.90

72.03

1.5

1.8

1.19

1.47

g/l

0.97

219

615

Other external causes of accidental injury

3247

11469

1.44

71.95

1.8

1.9

1.29

1.33

g/l

0.53

2979

10549

Other diseases of blood and blood-forming organs

353

1283

3.01

71.82

2.0

1.8

1.52

1.37

g/l

0.41

320

1175

Childhood asthma (age<16), excluding more controls

522

1744

2.45

71.52

1.7

1.21

1.25

g/l

0.29

488

1633

External causes of morbidity and mortality

2634

8953

1.50

71.45

1.8

1.9

1.27

1.31

g/l

0.43

2428

8222

Accidents

3243

11469

1.44

71.37

1.8

1.9

1.28

1.33

g/l

0.63

2980

10549

Diseases of pulp and periapical tissues, including avohilmo

4110

15670

1.38

71.27

1.9

1.8

1.26

1.31

g/l

0.86

3767

14315

Other viral diseases, not elsewhere classified

1122

6380

1.82

71.13

2.1

1.8

1.30

1.27

g/l

0.17

1052

5920

Diseases of oral cavity, salivary glands and jaws

2203

7421

1.56

70.98

1.9

1.8

1.30

1.36

g/l

0.43

2022

6718

Chronic viral hepatitis

315

1090

3.20

70.55

1.3

1.9

1.67

1.25

g/l

4.48

291

1020

Eosinophilia

150

318

5.97

70.52

1.8

1.6

1.08

1.43

g/l

1.40

138

295

Childhood asthma (age<16)

522

1758

2.43

70.36

1.7

1.21

1.25

g/l

0.27

488

1649

Sequelae with surgical and medical care as external cause

837

4398

1.99

70.21

1.9

1.24

1.37

g/l

1.03

770

3985

Systemic sclerosis, icd10

183

452

4.83

70.19

1.8

1.43

1.28

g/l

0.56

167

411

Missing teeth due to accident, extraction or parodontitis

2186

13851

1.52

70.00

1.9

1.41

1.32

g/l

0.79

1921

12622

Abnormal weight loss

446

1845

2.61

69.69

1.7

1.8

1.17

1.38

g/l

1.92

412

1671

Cellulitis

916

4970

1.92

69.38

2.0

1.8

1.32

g/l

0.01

830

4554

Weight loss

474

2020

2.52

69.20

1.8

1.9

1.15

1.38

g/l

2.38

438

1827

Other complications of surgical and medical care, not elsewhere classified

465

1962

2.54

69.20

2.2

1.9

1.30

1.34

g/l

0.13

437

1788

Other abnormal findings of blood chemistry

258

803

3.58

69.19

2.4

1.8

1.64

1.44

g/l

0.36

247

732

Obesity, other/unspecified

1351

8186

1.70

69.04

1.6

1.9

1.14

1.34

g/l

6.02

1245

7554

Early onset COPD

890

4800

1.94

68.78

1.9

1.20

1.34

g/l

1.28

815

4359

Other infectious diseases

375

1439

2.82

68.37

2.0

1.9

1.18

1.44

g/l

1.80

337

1310

Diseases of spleen

149

324

5.63

67.43

2.2

1.6

1.16

1.52

g/l

0.89

133

303

COPD, hospital admissions 3, with asthma pneumonia sepsis

982

4646

1.87

67.37

2.0

1.9

1.33

1.38

g/l

0.17

876

4135

Arthrosis

2518

9448

1.49

66.96

1.8

1.9

1.29

1.36

g/l

0.71

2295

8602

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

433

1800

2.58

66.71

2.4

1.8

1.33

1.39

g/l

0.16

402

1646

Hypertensive heart and/or renal disease

895

3571

1.93

66.65

1.7

2.2

1.23

1.56

g/l

3.24

800

3196

Other or unspecified immunodeficiency

18.13

66.36

4.6

1.9

1.17

1.51

g/l

0.40

Chronic laryngitis and laryngotracheitis

592

2805

2.23

66.32

1.7

1.8

1.31

1.39

g/l

0.38

518

2538

Disorders of conjunctiva

3197

18596

1.41

66.26

1.9

1.8

1.30

1.31

g/l

0.12

2938

17010

Other and unspecified diseases of blood and blood-forming organs

183

471

4.55

66.08

2.4

1.7

1.65

1.53

g/l

0.18

168

433

Gonarthrosis [arthrosis of knee](FG)

2484

9896

1.49

66.05

1.8

1.9

1.32

1.37

g/l

0.36

2229

8957

Other cataract

1581

7530

1.63

66.05

2.1

1.9

1.33

1.35

g/l

0.07

1451

6820

Cardiomyopathy

647

3167

2.13

65.95

2.0

1.9

1.30

1.40

g/l

0.39

602

2858

Coronary atherosclerosis

2261

9671

1.51

65.94

1.9

1.25

1.39

g/l

1.90

2073

8701

Glucagon-like peptide-1 (GLP-1) analogues

1126

6607

1.77

65.26

1.5

2.0

1.11

1.37

g/l

7.90

1029

6074

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1126

6607

1.77

65.26

1.5

2.0

1.11

1.37

g/l

7.90

1029

6074

Later onset COPD, excluding more controls

614

2238

2.19

65.05

1.6

1.8

1.49

1.52

g/l

0.06

551

1961

Mental and behavioural disorders due to alcohol

1913

12225

1.54

64.81

1.6

1.9

1.35

1.29

g/l

0.55

1721

11212

Paralytic ileus and intestinal obstruction

928

5148

1.86

64.71

2.0

1.9

1.29

1.43

g/l

0.73

851

4633

Other diseases of lip and oral mucosa

1552

9890

1.62

64.65

1.8

1.9

1.26

1.34

g/l

0.92

1409

9033

Use of interferon beta-1a

172

431

4.70

64.54

3.5

1.7

0.95

1.36

g/l

3.68

167

404

Total colectomy operation

252

811

3.49

64.31

2.0

1.8

1.21

1.37

g/l

0.72

237

754

Total colectomy

252

811

3.49

64.31

2.0

1.8

1.21

1.37

g/l

0.72

237

754

Benign neoplasm of other and ill-defined parts of digestive system

730

3787

2.02

63.78

1.9

1.8

1.39

1.36

g/l

0.09

678

3431

Other symptoms and signs involving the circulatory and respiratory systems

311

1122

2.98

63.60

1.9

2.0

1.08

1.34

g/l

2.23

286

1018

Diseases of salivary glands

1263

7690

1.70

63.57

1.9

1.8

1.23

1.34

g/l

1.60

1151

7032

Other metabolic disorders

567

2687

2.22

63.46

2.0

1.8

1.33

1.39

g/l

0.20

528

2483

Ischaemic heart disease, wide definition

2768

12128

1.44

63.41

1.8

1.9

1.29

1.37

g/l

0.82

2548

10996

Dizziness and giddiness

2789

15770

1.43

63.31

1.8

1.9

1.32

1.33

g/l

0.08

2531

14382

Herpesviral [herpes simplex] infections

1000

5727

1.81

63.20

2.1

1.8

1.29

1.34

g/l

0.34

927

5262

Disorders of choroid and retina

2923

14906

1.42

63.05

1.9

1.34

1.32

g/l

0.18

2641

13542

Symptoms and signs involving speech and voice

1263

7717

1.69

62.66

1.9

1.8

1.22

1.36

g/l

1.91

1155

7012

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1662

10769

1.58

62.56

1.5

1.9

1.36

1.29

g/l

0.72

1497

9870

Other diseases of hard tissues of teeth

2133

7385

1.52

62.38

1.8

1.30

1.36

g/l

0.40

1935

6688

Adjustment and management of implanted device

656

3295

2.07

62.28

1.8

1.35

1.47

g/l

0.39

600

2931

Inflammatory diseases of the central nervous system

406

1699

2.57

61.82

2.2

1.8

1.27

1.35

g/l

0.26

373

1560

Diseases of middle ear and mastoid

2210

12433

1.49

61.74

2.0

1.8

1.25

1.30

g/l

0.59

2044

11424

Pneumonia derived septicemia

217

654

3.75

61.68

2.9

1.8

1.38

1.49

g/l

0.16

197

594

Injury, poisoning and certain other consequences of external causes

2147

7221

1.52

61.55

1.8

1.9

1.34

g/l

0.04

1980

6619

Dental operations

2270

7926

1.50

61.42

1.9

1.8

1.29

1.33

g/l

0.30

2065

7181

Hypothyroidism, strict autoimmune, 3 medication purchases required

3134

15422

1.40

61.07

1.7

1.9

1.23

1.35

g/l

2.86

2826

14078

Acute suppurative otitis media

1083

5957

1.75

60.85

2.1

1.8

1.25

1.28

g/l

0.22

998

5544

Injuries to the head

4237

19830

1.33

60.59

1.8

1.9

1.28

1.31

g/l

0.45

3857

18141

Golimumab

223

693

3.64

60.44

1.7

1.8

1.25

1.29

g/l

0.15

213

647

Viral pneumonia (known virus, not influenza)

181

493

4.27

60.38

3.5

1.7

1.48

1.47

g/l

0.00

164

456

Kidney transplant status

300

1103

3.02

60.37

2.2

1.9

1.12

1.30

g/l

1.21

282

1027

Shoulder lesions

2740

11820

1.43

59.98

1.8

1.9

1.31

1.34

g/l

0.23

2505

10774

Intestinal malabsorption

261

891

3.24

59.97

1.8

1.07

1.44

g/l

2.57

233

822

Polyarthritis, unspecified

204

600

3.78

59.79

1.7

1.9

1.28

1.45

g/l

0.45

196

548

Coeliac disease

543

2595

2.21

59.78

1.9

1.12

1.34

g/l

3.84

493

2388

Cholecystitis

531

2506

2.22

59.76

1.7

1.9

1.25

1.40

g/l

1.22

470

2249

Benign neoplasm: Colon, unspecified

929

5298

1.82

59.66

1.7

1.9

1.28

1.35

g/l

0.38

833

4768

Vascular disorders of the intestines

291

1050

2.97

59.39

1.9

1.7

1.32

1.44

g/l

0.39

269

930

Dermatitis due to substances taken internally

285

1023

3.04

59.38

2.3

1.8

1.16

1.35

g/l

0.72

262

938

Hyperparathyroidism

686

3521

2.01

59.29

1.8

1.24

1.41

g/l

1.45

618

3147

Use of teriflunomide

108

200

7.00

59.23

3.2

1.6

0.91

1.32

g/l

2.09

108

189

Gingivitis and periodontal diseases

3895

15102

1.35

59.09

1.9

1.29

1.32

g/l

0.33

3577

13781

Other specified/unspecified necrotizing vasculopathies

117

232

6.26

59.03

2.1

1.7

0.89

1.45

g/l

2.27

111

214

Hernia

3494

17450

1.36

58.92

1.9

1.36

1.31

g/l

0.64

3182

15933

Migraine with aura

955

5506

1.79

58.64

1.7

1.8

1.26

1.34

g/l

1.23

897

5088

Drug-induced cataract

173

468

4.37

58.64

2.8

1.7

1.23

1.32

g/l

0.27

162

428

Lumbar disc prolapse

2289

12246

1.46

58.61

1.8

1.9

1.32

1.35

g/l

0.19

2101

11210

Other arthrosis

1797

8247

1.54

58.60

1.8

1.9

1.29

1.37

g/l

0.59

1631

7495

Endocarditis

199

584

3.79

58.54

1.8

1.15

1.48

g/l

1.35

188

531

Other chronic obstructive pulmonary disease, including avohilmo

1863

10360

1.52

58.38

1.8

2.0

1.32

1.34

g/l

0.14

1689

9362

Unspecified haematuria

1489

7916

1.60

58.36

1.9

1.27

1.34

g/l

0.46

1332

7184

Diseases of the myoneural junction and muscle

518

2454

2.23

58.33

1.8

1.9

1.12

1.40

g/l

3.23

467

2220

Suggestive for eosinophilic asthma

412

1779

2.47

58.30

1.9

1.23

1.40

g/l

0.89

385

1609

Other viral diseases, not elsewhere classified

788

4308

1.90

57.91

2.3

1.8

1.29

1.28

g/l

0.03

735

3986

Nephrotic syndrome

206

628

3.76

57.89

2.2

1.7

1.32

1.35

g/l

0.05

193

583

Substance use, excluding alcohol

816

4539

1.87

57.08

1.6

1.9

1.35

1.29

g/l

0.45

750

4184

COPD-related respiratory insufficiency

465

2130

2.30

56.82

2.0

1.9

1.15

1.36

g/l

1.82

421

1899

Conjunctivitis

2865

17491

1.39

56.70

2.0

1.8

1.32

1.31

g/l

0.11

2629

16018

Other and unspecified aplastic anaemias

108

208

6.63

56.65

2.3

1.5

1.43

1.22

g/l

0.37

192

Other retinal disorders

2236

12189

1.46

56.60

1.9

1.36

1.32

g/l

0.26

2012

11027

Osteonecrosis

302

1148

2.86

56.49

2.8

1.7

0.99

1.43

g/l

3.33

276

1045

COPD, early/later onset

1556

8564

1.57

56.43

1.8

1.9

1.35

g/l

0.01

1405

7706

Secondary right heart disease

220

704

3.46

56.38

2.4

1.7

1.22

1.61

g/l

1.25

211

638

COPD, hospital admissions

1542

8500

1.57

56.35

1.8

1.9

1.36

1.35

g/l

0.01

1392

7644

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1019

6017

1.74

56.33

1.8

1.34

1.30

g/l

0.33

925

5598

Psoriatic arthropathies

434

1945

2.36

55.99

1.6

1.9

1.19

1.37

g/l

1.06

397

1774

Thyroiditis, ILD-related definition

458

2096

2.30

55.97

1.9

1.7

1.27

1.41

g/l

0.99

415

1915

Disorders of oesophagus in diseases classified elsewhere

145

357

4.76

55.61

2.5

1.7

1.21

1.47

g/l

0.84

131

325

151

382

4.55

55.57

2.1

2.0

1.04

1.56

g/l

2.24

141

342

Temporal arteritis

200

611

3.67

55.51

1.5

1.8

1.19

1.47

g/l

0.78

182

544

Other and unspecified drugs and medicaments

393

1701

2.47

55.46

2.5

1.9

1.31

1.41

g/l

0.25

366

1549

Alcohol use disorder, ICD-based

1529

10051

1.56

55.26

1.5

1.9

1.37

1.29

g/l

0.70

1378

9214

COPD related to multimorbidity

1337

7171

1.62

54.94

1.7

1.9

1.27

1.37

g/l

0.72

1207

6417

Non-selective monoamine reuptake inhibitors

1364

8424

1.60

54.91

1.7

1.9

1.23

1.34

g/l

1.41

1231

7686

Mantle cell lymphoma

127

8.50

54.83

2.2

1.3

0.88

1.07

g/l

0.84

118

Invasive ventilation

346

1425

2.62

54.72

2.0

1.8

1.20

1.40

g/l

1.10

311

1310

Iridocyclitis

890

5143

1.80

54.66

1.9

1.26

1.34

g/l

0.60

838

4710

Dental caries, including avohilmo

2753

10141

1.41

54.60

1.9

1.8

1.36

1.30

g/l

0.57

2522

9205

Spinal stenosis

1719

8741

1.53

54.29

1.9

1.32

1.39

g/l

0.54

1545

7908

Other pulmonary heart/vessel disease

234

793

3.24

54.28

2.4

1.8

1.23

1.63

g/l

1.34

225

715

Migraine without aura

795

4457

1.85

53.92

1.9

1.8

1.23

1.32

g/l

1.79

734

4143

Injuries to the abdomen, lower back, lumbar spine and pelvis

1433

9234

1.57

53.84

2.0

1.9

1.35

1.34

g/l

0.04

1286

8374

Pericarditis

194

591

3.63

53.76

2.6

1.8

1.15

1.54

g/l

1.61

186

540

Voice disturbances

1012

6085

1.72

53.67

1.9

1.18

1.36

g/l

2.71

935

5529

Nonsuppurative otitis media

941

4771

1.76

53.50

2.0

1.8

1.17

1.31

g/l

2.02

880

4401

Myeloproliferative diseases

366

1563

2.51

53.26

1.8

1.9

1.51

1.47

g/l

0.09

332

1409

Psoriasis vulgaris

749

4151

1.88

53.24

1.7

1.9

1.34

g/l

0.00

683

3819

Fracture of lumbar spine and pelvis

780

4358

1.85

53.24

2.1

1.8

1.39

1.38

g/l

0.05

696

3900

Myelodysplastic syndrome

126

7.91

53.20

1.7

1.3

1.18

1.04

g/l

0.46

112

Calcific aortic valvular stenosis

955

5491

1.74

52.65

1.8

1.9

1.37

1.41

g/l

0.14

844

4873

Calcific aortic valvular stenosis, operated

955

5491

1.74

52.65

1.8

1.9

1.37

1.41

g/l

0.14

844

4873

Calcific aortic valvular stenosis, including rheumatic fever

956

5494

1.74

52.59

1.8

1.9

1.40

g/l

0.00

845

4876

Calcific aortic valvular stenosis, diagnosis (helper)

952

5475

1.74

52.43

1.8

1.9

1.37

1.41

g/l

0.14

841

4857

Operations 2 for CAVS

952

5475

1.74

52.43

1.8

1.9

1.37

1.41

g/l

0.14

841

4857

Personality disorders, excluding more controls

943

5586

1.74

52.40

1.7

1.8

1.28

1.29

g/l

0.09

847

5211

Subjective visual disturbances

963

5762

1.73

52.03

1.8

1.9

1.22

1.35

g/l

1.39

872

5255

Presence of cardiac and vascular implants and grafts

1420

6849

1.58

51.74

1.6

1.9

1.27

1.39

g/l

0.75

1288

6158

Other peripheral vascular diseases

363

1566

2.47

51.53

1.7

1.9

1.30

1.46

g/l

1.02

332

1423

Injuries to the thorax

1605

10806

1.52

51.51

1.9

1.33

g/l

0.01

1468

9808

Preparatory care for dialysis

235

827

3.16

51.36

1.8

1.16

1.43

g/l

0.89

221

761

Suppurative and unspecified otitis media

1389

8022

1.57

51.31

2.1

1.8

1.28

g/l

0.01

1286

7426

Hypoparathyroidism

201

647

3.47

51.30

2.8

1.8

1.14

1.38

g/l

1.39

181

583

Coxarthrosis [arthrosis of hip](FG)

1697

8041

1.51

51.28

1.8

2.0

1.15

1.40

g/l

4.85

1529

7224

Disorders of synovium and tendon

1901

11556

1.47

51.15

1.7

1.9

1.25

1.35

g/l

1.33

1731

10562

Portal vein thrombosis

122

282

5.19

51.10

1.5

1.9

1.23

1.32

g/l

0.26

117

259

Enteropathic arthropathies

147

388

4.31

50.91

1.7

1.37

1.48

g/l

0.24

136

358

Other and unspecified urticaria

797

4558

1.82

50.90

1.9

1.8

1.30

1.31

g/l

0.10

731

4211

Other abnormal immunological findings in serum

137

345

4.60

50.87

2.1

1.6

1.34

1.40

g/l

0.14

127

317

Paracetamol or NSAID medication

663

1711

2.00

50.69

1.8

1.9

1.45

1.25

g/l

0.80

612

1570

Other skin changes

703

3880

1.89

50.62

2.3

1.9

1.42

1.35

g/l

0.27

651

3490

Nonorganic sleeping disorders, excluding more controls

729

4060

1.86

50.58

1.7

1.8

1.29

1.31

g/l

0.10

669

3767

Diseases of pulp and periapical tissues and dental caries

2441

8939

1.42

50.56

1.9

1.8

1.34

1.30

g/l

0.29

2234

8109

Other or unspecified ileus, impaction or obstruction

646

3467

1.93

50.36

1.9

1.8

1.36

1.38

g/l

0.07

591

3097

Need for other prophylactic measures

297

1187

2.72

50.34

2.2

1.8

1.15

1.34

g/l

0.98

279

1097

Acute generalized exanthematous pustulosis

239

858

3.06

50.16

2.3

1.9

1.17

1.48

g/l

1.08

223

793

Emphysema

301

1205

2.66

50.13

1.9

2.0

1.17

1.38

g/l

1.29

276

1073

Caries of dentine, including avohilmo

2939

11086

1.38

50.08

1.9

1.38

1.30

g/l

0.75

2709

10080

Pacemaker

1062

6283

1.66

50.07

1.8

1.9

1.32

1.39

g/l

0.30

958

5590

Pneumococcal septicemia

200

653

3.44

49.98

2.9

1.8

1.43

1.42

g/l

0.01

183

602

Conduction disorders

976

4747

1.71

49.97

1.9

1.31

1.41

g/l

0.54

878

4267

Generalized skin eruption due to drugs and medicaments

220

758

3.22

49.90

2.4

1.8

1.16

1.51

g/l

1.13

204

700

Giant cell arteritis with polymyalgia rheumatica

200

653

3.42

49.88

1.5

1.8

1.19

1.58

g/l

1.09

182

587

Raynaud syndrome

392

1774

2.36

49.84

1.8

1.37

1.38

g/l

0.06

365

1626

Other diseases of stomach and duodenum

282

1101

2.74

49.64

1.7

1.9

1.25

1.44

g/l

1.01

265

992

Biological medicines for asthma

140

367

4.48

49.52

1.6

1.06

1.40

g/l

1.95

130

342

Hypermobility syndrome

256

955

2.89

49.49

2.1

1.8

1.26

1.36

g/l

0.72

239

888

Other coagulation defects

341

1462

2.49

49.21

2.1

1.8

1.28

1.44

g/l

0.64

322

1342

Pyogenic arthritis

290

1151

2.69

49.21

1.8

2.0

1.14

1.46

g/l

2.02

263

1041

Elevated blood glucose level

359

1573

2.43

49.14

2.1

1.8

1.18

1.39

g/l

1.64

330

1424

Hypertensive Heart Disease

756

3318

1.84

49.03

1.6

2.2

1.24

1.57

g/l

3.04

671

2972

Diabetic nephropathy, excluding more controls

609

2650

1.99

48.92

1.6

1.7

1.08

1.30

g/l

2.42

562

2374

Pain and other conditions associated with female genital organs and menstrual cycle

772

4043

1.81

48.89

1.7

1.8

1.26

1.34

g/l

1.13

695

3703

Pneumonia due to Streptococcus pneumoniae

202

666

3.29

48.88

2.3

1.6

1.03

1.32

g/l

1.89

180

613

Polycystic ovarian syndrome, consortium definition

2560

11060

1.40

48.75

1.8

1.33

1.35

g/l

0.22

2340

10094

Other CVD

687

3802

1.87

48.74

2.1

1.8

1.31

1.37

g/l

0.21

614

3390

Other and unspecified effects of external causes

1076

6734

1.65

48.59

1.9

1.8

1.43

1.30

g/l

0.98

992

6215

Pruritus

445

2133

2.19

48.53

1.9

1.8

1.59

1.37

g/l

0.60

405

1939

Hypersplenism

12.90

48.46

2.9

1.9

1.28

1.75

g/l

0.42

Peripheral artery disease

1413

7421

1.55

48.43

1.7

1.9

1.24

1.42

g/l

1.84

1282

6624

Other and unspecified acquired haemolytic anaemias

174

6.75

48.29

2.5

1.8

2.02

1.58

g/l

0.43

158

Retention of urine

1146

5943

1.62

47.89

2.0

1.9

1.37

1.38

g/l

0.04

1027

5364

Other and unspecified tonsillitis

1218

6566

1.60

47.84

1.9

1.7

1.28

1.26

g/l

0.12

1128

6102

Other specified/unspecified inflammatory spondylopathies

242

894

2.93

47.75

1.7

1.9

1.33

1.52

g/l

0.74

229

833

AV-block

580

2660

1.97

47.66

1.8

1.9

1.29

1.49

g/l

0.79

517

2365

Other juvenile arthritis

215

748

3.13

47.51

2.0

1.9

1.27

1.30

g/l

0.19

197

698

Myositis

154

441

3.94

47.36

1.7

1.04

1.53

g/l

1.93

145

399

Irregular menses

1731

9440

1.48

47.35

1.9

1.8

1.33

1.34

g/l

0.18

1602

8676

Abnormal findings on examination of urine, without diagnosis

231

841

3.02

47.23

2.7

1.8

1.12

1.46

g/l

1.82

219

772

Excessive, frequent and irregular menstruation

1418

5082

1.56

47.20

1.8

1.32

1.35

g/l

0.20

1291

4614

Viral and other specified intestinal infections

1048

6318

1.64

47.03

2.0

1.8

1.17

1.29

g/l

2.11

969

5834

Deforming dorsopathies

1013

6304

1.65

46.66

1.9

1.30

1.37

g/l

0.36

922

5745

Disorders resulting from impaired renal tubular function

207

718

3.22

46.64

1.8

1.12

1.48

g/l

1.70

189

668

Intestinal stricture

1087

6883

1.62

46.64

2.0

1.9

1.34

1.35

g/l

0.01

1000

6205

Myocarditis

204

693

3.14

46.46

2.3

2.0

1.33

1.58

g/l

0.49

187

634

Juvenile arthritis (FINNGEN)

235

868

2.93

46.38

2.0

1.9

1.25

1.28

g/l

0.16

216

809

Somatoform disorder

645

3564

1.88

46.29

1.8

1.23

1.35

g/l

1.01

584

3287

Periodontitis

3486

17985

1.31

46.18

1.9

1.30

1.32

g/l

0.17

3166

16418

Rash and other nonspecific skin eruption

414

1976

2.22

45.92

2.0

1.8

1.18

1.33

g/l

1.04

397

1807

Injuries to the knee and lower leg

4417

19419

1.28

45.80

1.8

1.9

1.25

1.32

g/l

1.78

4046

17733

Polyarteritis nodosa and related conditions

105

235

5.32

45.69

2.1

1.7

1.04

1.43

g/l

1.20

100

215

Cardiomyopathy in other diseases

10.12

45.64

3.7

1.5

1.85

1.77

g/l

0.03

Reactive arthropathies, FINNGEN

299

1249

2.54

45.52

1.9

1.24

1.35

g/l

0.55

282

1143

Other disorders of bone

762

4441

1.78

45.48

2.1

1.8

1.17

1.35

g/l

1.95

683

4097

Atopic dermatitis, strict definition with reimbursement

1140

7079

1.60

45.36

1.8

1.20

1.25

g/l

0.72

1069

6567

Soft tissue disorders related to use, overuse and pressure

962

5955

1.66

45.33

1.8

1.9

1.41

1.38

g/l

0.14

871

5417

Inflammatory diseases of female pelvic organs

2158

11462

1.41

45.26

1.8

1.37

1.34

g/l

0.31

1958

10482

Gonarthrosis

2104

8547

1.42

45.18

1.8

1.9

1.32

1.37

g/l

0.41

1891

7767

Hyperkinetic disorders, excluding more controls

454

2144

2.11

45.08

1.5

1.8

1.25

1.23

g/l

0.12

422

2012

Special screening examination for infectious and parasitic diseases

835

3618

1.74

44.98

1.8

1.7

1.29

1.28

g/l

0.06

747

3354

Fracture of rib(s), sternum and thoracic spine

1050

6652

1.62

44.96

1.9

1.24

1.32

g/l

0.65

963

6012

Allergic rhinitis

1207

7807

1.57

44.77

1.8

1.20

1.28

g/l

1.34

1101

7264

Other disorders of kidney and ureter

511

2654

2.02

44.74

2.1

1.8

1.38

1.37

g/l

0.02

468

2404

Duodenal ulcer

380

1764

2.25

44.70

1.5

1.9

1.18

1.39

g/l

1.32

348

1568

Chronic periodontitis, including avohilmo

3465

17981

1.31

44.69

1.9

1.30

1.32

g/l

0.13

3147

16414

Unknown and unspecified causes of morbidity

270

1085

2.62

44.36

2.2

1.8

1.17

1.40

g/l

1.47

257

974

Ankylosing spondylitis

381

1786

2.25

44.18

1.5

1.9

1.26

1.42

g/l

1.12

360

1643

Keratitis

1294

8619

1.54

44.14

1.9

1.8

1.27

1.32

g/l

0.46

1189

7877

Type 1 diabetes

933

5763

1.66

44.09

1.7

1.9

1.21

1.34

g/l

1.71

854

5290

Lung diseases due to external agents

501

2601

2.00

43.54

1.8

1.9

1.29

1.41

g/l

0.53

441

2325

Hypotension

577

3137

1.91

43.44

2.2

1.8

1.33

1.39

g/l

0.17

512

2790

Recurrent aphthous stomatitis , including avohilmo

573

3121

1.92

43.31

2.1

1.9

1.12

1.36

g/l

4.32

540

2862

Isolated proteinuria

170

551

3.47

43.15

2.8

1.7

1.05

1.44

g/l

2.28

161

513

Coxibs

1004

3245

1.66

43.08

1.8

1.9

1.23

1.38

g/l

1.20

908

2959

Idiopathic gout

361

1675

2.28

43.02

1.7

1.9

1.23

1.44

g/l

0.52

338

1501

Reactive arthropathies

354

1629

2.29

42.90

1.8

1.9

1.27

1.39

g/l

0.67

334

1491

Acute pharyngitis

571

3079

1.91

42.89

1.7

1.13

1.28

g/l

3.02

530

2889

L01XX Other antineoplastic agents

260

1053

2.67

42.80

2.1

1.9

1.12

1.56

g/l

2.51

224

945

Ulcerative proctitis

282

1183

2.55

42.79

1.9

1.8

1.22

1.39

g/l

0.94

263

1097

Osteomyelitis

284

1196

2.54

42.77

2.1

1.8

1.36

1.43

g/l

0.16

255

1103

Adverse effects, not elsewhere classified

778

4641

1.74

42.75

2.0

1.8

1.43

1.32

g/l

0.59

716

4289

Neuromuscular dysfunction of bladder

372

1752

2.24

42.67

2.1

2.0

1.21

1.42

g/l

1.36

344

1598

Other acute viral hepatitis

105

250

5.08

42.58

1.6

1.59

1.40

g/l

0.44

100

230

Internal derangement of knee

1243

8219

1.54

42.54

1.9

1.34

g/l

0.04

1117

7485

Fissure and fistula of anal and rectal regions

847

5165

1.69

42.39

1.9

1.8

1.14

1.35

g/l

2.81

770

4712

Atherosclerosis, excluding cerebral and coronary sclerosis

1292

6814

1.53

42.37

1.7

1.9

1.24

1.43

g/l

1.93

1172

6063

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

407

1995

2.15

42.13

2.2

1.9

1.16

1.38

g/l

1.14

382

1810

Haemorrhoids and perianal venous thrombosis

1050

6732

1.59

42.02

1.9

1.41

1.38

g/l

0.09

946

6067

Secondary thrombocytopenia

100

232

5.25

41.99

2.7

1.5

1.28

1.36

g/l

0.15

213

Anterior Iridocyclitis

766

4572

1.73

41.98

1.9

1.29

1.33

g/l

0.19

725

4194

Complications of internal orthopaedic prosthetic devices, implants and grafts

758

4513

1.73

41.72

1.7

1.9

1.13

1.42

g/l

4.48

673

4042

Statin medication

2584

10861

1.36

41.60

1.6

2.0

1.15

1.40

g/l

12.22

2383

9966

Congenital malformations, deformations and chromosomal abnormalities

2159

15149

1.38

41.59

1.9

1.8

1.29

g/l

0.00

2025

13902

Stomatitis and related lesions

754

4496

1.74

41.52

2.0

1.8

1.18

1.31

g/l

1.66

702

4125

Injuries to the ankle and foot

2584

17366

1.34

41.43

1.8

1.30

1.29

g/l

0.11

2361

15960

Other diseases of oesophagus

348

1613

2.26

41.28

1.9

2.0

1.65

1.41

g/l

0.46

317

1448

Coxarthrosis

1582

7232

1.47

41.25

1.8

1.9

1.16

1.39

g/l

4.04

1422

6539

Diplopia

509

2713

1.96

41.18

2.1

1.8

1.25

1.37

g/l

0.50

477

2468

Conjunctivitis (acute, non atopic)

1050

6767

1.59

41.17

2.1

1.8

1.29

1.30

g/l

0.05

972

6227

Cerebrovascular diseases

2496

13146

1.36

41.12

1.8

1.9

1.20

1.36

g/l

3.89

2251

11918

Acute and subacute iridocyclitis

721

4258

1.75

41.11

1.9

1.8

1.30

1.34

g/l

0.20

682

3910

Arthropathic psoriasis

462

2389

2.03

41.09

1.6

1.9

1.14

1.35

g/l

2.92

421

2207

Disease of hard tissues of teeth, NOS

1929

7195

1.43

40.95

1.9

1.8

1.25

1.35

g/l

1.10

1766

6524

Exposure to other specified factors

2740

19217

1.33

40.94

1.8

1.9

1.25

1.30

g/l

0.77

2498

17615

Other and unspecified coagulation defects

246

993

2.68

40.86

2.2

1.8

1.38

1.51

g/l

0.32

234

919

Other encephalitis

162

528

3.44

40.68

2.3

1.7

1.13

1.43

g/l

1.15

144

489

Persons encountering health services for specific procedures, not carried out

355

1674

2.24

40.59

1.9

1.8

1.42

1.37

g/l

0.17

327

1544

Migraine with aura and triptan purchases

611

3456

1.83

40.56

1.7

1.8

1.26

1.33

g/l

0.70

576

3203

Polyuria

769

4635

1.71

40.45

2.1

1.9

1.29

1.39

g/l

0.45

684

4183

Problems related to lifestyle

413

2063

2.09

40.26

1.6

1.8

1.45

1.32

g/l

0.53

365

1891

Drug-induced osteoporosis

100

241

5.04

40.02

3.0

1.7

1.28

1.31

g/l

0.06

221

Fentanyl

348

1630

2.22

39.81

2.3

1.7

1.11

1.38

g/l

1.93

309

1459

Disorders of muscles

402

2001

2.10

39.65

1.6

1.9

1.08

1.37

g/l

3.26

376

1819

Amputation

364

1747

2.18

39.51

1.7

1.9

1.22

1.48

g/l

1.28

321

1556

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1046

6740

1.57

39.46

1.9

1.8

1.20

1.31

g/l

2.25

975

6257

Dialysis

203

763

2.91

39.16

2.2

1.7

1.04

1.39

g/l

1.93

190

710

COPD, hospital admissions 1, only main diagnosis

1098

6181

1.56

38.88

1.8

1.9

1.41

1.37

g/l

0.13

979

5532

Suppurative and necrotic conditions of lower respiratory tract

251

1046

2.58

38.85

2.3

1.8

1.34

1.43

g/l

0.18

227

956

Atypical mycobacterium lung infection

208

5.27

38.80

1.9

1.8

1.32

1.38

g/l

0.09

184

Pain in thoracic spine

568

3190

1.84

38.60

2.0

1.8

1.33

1.37

g/l

0.11

534

2929

Encephalitis

167

571

3.25

38.58

2.3

1.7

1.13

1.41

g/l

1.13

149

528

Vitamin deficiency, wide

219

858

2.75

38.55

2.2

1.8

1.32

1.45

g/l

0.35

198

785

Vitamin deficiency

219

858

2.75

38.55

2.2

1.8

1.32

1.45

g/l

0.35

198

785

Major coronary heart disease event excluding revascularizations

1929

9337

1.40

38.54

1.8

2.0

1.23

1.41

g/l

2.68

1750

8383

Other neurological diseases

2462

14649

1.34

38.50

2.0

1.9

1.30

1.34

g/l

0.32

2248

13279

Other disorders of ear

3274

16793

1.29

38.48

2.0

1.9

1.34

1.30

g/l

0.33

2957

15349

Congenital malformations, deformations and chromosomal abnormalities

2343

16284

1.35

38.46

1.9

1.8

1.28

1.30

g/l

0.14

2198

14940

Cervical disc disorders

1214

8215

1.51

38.27

1.9

1.28

1.37

g/l

0.62

1087

7490

Pollen allergy

761

4588

1.69

38.15

1.8

1.25

1.26

g/l

0.05

693

4285

Chronic myeloid leukaemia, including Hilmo

148

6.22

38.07

1.3

1.10

1.14

g/l

0.06

137

Other embolism and thrombosis

472

2520

1.95

37.89

2.1

1.9

1.12

1.41

g/l

3.47

436

2286

Dermatographic urticaria

296

1340

2.35

37.72

2.1

1.8

1.32

1.41

g/l

0.36

274

1242

Simple and mucopurulent chronic bronchitis

185

675

2.94

37.31

1.8

1.9

1.24

1.45

g/l

0.77

175

610

CR(E)ST syndrome

111

303

4.31

37.30

1.7

1.62

1.34

g/l

0.84

276

Intracranial injury

2039

14327

1.37

37.21

1.8

1.9

1.29

1.32

g/l

0.26

1836

13076

Small fibre neuropathy

162

557

3.25

37.20

3.0

1.6

1.74

1.46

g/l

0.54

148

510

Rotator cuff syndrome

2048

10859

1.37

37.15

1.7

1.9

1.26

1.34

g/l

0.80

1891

9883

Transport accidents

1624

9990

1.42

37.02

1.8

1.9

1.27

1.32

g/l

0.53

1494

9201

Other disorders of eye and adnexa

553

3130

1.84

36.88

2.0

1.8

1.17

1.33

g/l

1.93

510

2882

Spondylopathies in diseases classified elsewhere

191

5.27

36.83

4.3

1.8

0.64

1.79

g/l

2.45

172

Misadventures to patients during surgical and medical care

529

2955

1.86

36.80

2.0

1.8

1.33

1.38

g/l

0.20

481

2691

Diabetic maculopathy, excluding more controls

403

2063

2.04

36.71

1.5

1.9

1.09

1.44

g/l

3.62

361

1874

Aspergillosis

162

6.01

36.70

2.6

1.5

1.22

1.37

g/l

0.19

146

Hernia of abdominal wall

1544

11022

1.43

36.59

1.8

1.9

1.35

1.33

g/l

0.15

1412

10032

Localized swelling, mass and lump of skin and subcutaneous tissue

1102

7388

1.53

36.57

2.0

1.8

1.29

1.30

g/l

0.06

1032

6717

Disorder of lipoprotein metabolism, unspecified

443

2343

1.96

36.48

1.7

1.8

1.10

1.48

g/l

5.44

403

2097

Postviral fatigue syndrome

155

5.99

36.26

2.3

1.8

1.23

1.41

g/l

0.36

146

Open wound of lower leg

567

3252

1.81

36.02

1.8

1.23

1.35

g/l

0.94

512

2970

Chronic diseases of tonsils and adenoids

2780

13584

1.31

36.01

1.8

1.9

1.26

1.33

g/l

0.78

2579

12468

Viral and other specified intestinal infections

773

4694

1.65

35.63

2.1

1.7

1.22

1.28

g/l

0.53

714

4332

Atopic dermatitis

2063

12636

1.36

35.50

1.7

1.8

1.25

1.29

g/l

0.36

1922

11645

Abnormality of white blood cells, not elsewhere classified

155

5.95

35.33

2.0

1.6

1.24

1.41

g/l

0.26

142

Postprocedural endocrine and metabolic disorders, not elsewhere classified

455

2460

1.92

35.15

1.9

1.8

1.29

1.39

g/l

0.44

426

2268

Myocardial infarction

1523

7614

1.43

35.00

1.8

2.0

1.17

1.42

g/l

3.95

1385

6844

Unspecified fall

1736

12532

1.39

35.00

2.0

1.9

1.34

1.31

g/l

0.19

1562

11435

Other psoriatic arthropathies

415

2189

1.99

34.93

1.6

1.9

1.20

1.31

g/l

0.56

379

2016

Ankylosing spondylitis, ICD10

371

1886

2.07

34.84

1.5

1.9

1.26

1.36

g/l

0.61

351

1750

Ovarian cyst

1240

4867

1.50

34.76

1.8

1.30

1.35

g/l

0.61

1147

4418

Open wound of head

1856

13250

1.37

34.70

1.9

1.30

1.31

g/l

0.04

1671

12075

Chronic nephritic syndrome

190

734

2.82

34.70

2.5

1.8

1.31

1.43

g/l

0.22

178

681

Liver disorders in diseases classified elsewhere

12.64

34.68

1.6

1.7

2.09

1.02

g/l

3.49

Cerebral cysts

251

1099

2.43

34.66

1.9

1.8

1.27

1.41

g/l

0.67

234

1006

Acetic acid derivatives and related substances

956

3177

1.59

34.54

1.7

1.9

1.23

1.38

g/l

1.45

869

2892

Rosacea

452

2460

1.92

34.43

2.0

1.8

1.35

1.37

g/l

0.06

415

2262

Psoriatic arthropathies, ICD10

425

2271

1.96

34.40

1.6

1.9

1.19

1.31

g/l

0.69

388

2095

Peripheral artery operations in Hilmo

420

2225

1.95

34.33

1.7

1.9

1.31

1.44

g/l

0.49

374

1969

Behavioural syndromes associated with physiological disturbances and physical factors

3303

18661

1.27

34.22

1.7

1.9

1.32

1.30

g/l

0.16

3013

17074

Acute peritonitis

263

1181

2.36

34.19

1.9

1.08

1.42

g/l

2.48

241

1080

Phlebitis and thrombophlebitis (not including DVT)

772

4864

1.63

34.07

2.2

1.9

1.17

1.39

g/l

2.79

707

4433

Diabetic nephropathy

611

3602

1.75

33.86

1.6

1.7

1.08

1.23

g/l

1.59

564

3245

Colectomy operation

589

3480

1.75

33.68

2.1

1.9

1.44

1.38

g/l

0.16

541

3139

Postprocedural disorders of nervous system

308

1481

2.20

33.67

2.1

1.8

1.18

1.38

g/l

1.62

292

1372

Postmenopausal osteoporosis with pathological fracture

238

1032

2.45

33.57

2.0

1.8

1.36

1.40

g/l

0.09

215

899

Renal tubulo-interstitial disorders in diseases classified elsewhere

178

5.35

33.51

3.8

1.6

0.85

1.82

g/l

1.65

163

Microscopic polyangiitis

118

7.05

33.45

2.1

1.8

0.88

1.50

g/l

1.31

104

Ocular pain

340

1700

2.11

33.43

2.1

1.8

1.21

1.42

g/l

1.48

315

1559

Other problems related to primary support group, including family circumstances

471

2551

1.87

33.16

2.1

1.8

1.12

1.27

g/l

2.23

440

2385

Diseases of peritoneum

383

2004

2.00

32.92

1.9

1.12

1.42

g/l

3.21

354

1822

Special screening examination for other diseases and disorders

375

1941

2.00

32.80

1.6

1.9

1.21

1.34

g/l

0.43

347

1759

Folate deficiency anaemia

148

5.68

32.74

2.2

1.8

1.90

1.37

g/l

0.55

135

Other specified/unspecified bacterial intestinal infections

272

1262

2.29

32.68

1.9

1.8

1.15

1.42

g/l

1.35

240

1148

Disorders of ocular muscles, binocular movement, accommodation and refraction

1667

12172

1.38

32.62

2.0

1.8

1.30

g/l

0.00

1542

11181

Migraine without aura and triptan purchases

612

3684

1.71

32.54

1.8

1.23

1.31

g/l

1.27

568

3423

Arthropathies in other diseases classified elsewhere

161

589

2.95

32.51

1.8

1.9

1.35

1.44

g/l

0.15

143

537

Temporomandibular joint disorders, including avohilmo

1552

11149

1.40

32.49

1.9

1.8

1.24

1.33

g/l

1.73

1428

10261

Poisoning by drugs, medicaments and biological substances

873

5720

1.57

32.46

1.7

1.8

1.35

1.32

g/l

0.21

789

5302

Post-traumatic stress disorder

327

1627

2.10

32.33

1.6

1.8

1.47

1.34

g/l

0.43

297

1525

Donors of organs and tissues

265

4.20

32.31

3.3

1.5

0.96

1.22

g/l

0.54

246

Certolizumab pegol

110

327

3.80

32.19

1.7

1.8

1.36

1.34

g/l

0.05

104

296

Haemorrhage, not elsewhere classified

149

524

3.04

32.14

1.6

1.8

1.12

1.52

g/l

1.55

137

474

Meniscus derangement

1751

8689

1.38

32.13

1.9

1.33

1.36

g/l

0.22

1605

7911

Exclusions for E4_PCOS_CONSORTIUM

2571

12517

1.30

32.09

1.7

1.8

1.27

1.33

g/l

0.91

2366

11486

Other dialysis

166

628

2.93

31.97

1.9

1.8

1.07

1.46

g/l

1.67

154

583

Benign neoplasm: Caecum

398

2135

1.95

31.87

1.7

1.9

1.49

1.38

g/l

0.31

367

1933

Osteonecrosis due to drugs

265

4.25

31.80

3.9

1.7

0.68

1.57

g/l

2.72

241

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1100

7589

1.48

31.67

1.7

1.8

1.25

1.32

g/l

0.55

998

6957

Cervicalgia

701

4391

1.64

31.67

1.7

1.9

1.25

1.39

g/l

0.84

639

4000

Chronic periodontitis, complicated

1833

13639

1.36

31.64

1.9

1.34

1.32

g/l

0.13

1659

12438

Contact with and exposure to communicable diseases

1130

7800

1.47

31.61

2.3

1.8

1.28

1.27

g/l

0.04

1067

7246

Cardiomyopathies, Primary/intrinsic

401

2154

1.93

31.56

1.6

1.9

1.21

1.42

g/l

1.07

376

1935

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1183

8281

1.46

31.55

1.9

1.31

1.33

g/l

0.11

1101

7569

Angina pectoris

1766

8716

1.37

31.42

1.7

2.0

1.25

1.41

g/l

1.88

1620

7832

Phobic anxiety disorders

503

2897

1.79

31.29

1.9

1.8

1.29

1.31

g/l

0.08

464

2701

Diabetic retinopathy, excluding more controls

946

3497

1.56

31.21

1.6

1.7

1.15

1.31

g/l

2.24

852

3140

Sleep disorders

3135

18149

1.26

31.10

1.7

1.9

1.33

1.31

g/l

0.16

2861

16610

Cardiodefibrillation

1117

7737

1.47

31.08

2.0

1.9

1.21

1.40

g/l

1.90

1029

6938

Myeloproliferative diseases (CML excluded)

291

1414

2.17

31.00

2.0

1.9

1.62

1.42

g/l

0.54

262

1280

Carrier of infectious disease

135

464

3.22

30.97

2.0

1.6

1.30

1.53

g/l

0.59

125

425

Other and unspecified rosacea

342

1762

2.04

30.94

1.8

1.22

1.40

g/l

0.69

313

1617

Menorrhagia

1172

4475

1.48

30.92

1.8

1.9

1.35

g/l

0.02

1067

4047

UC patients in KELA-register (code 208), prior to 1994

198

825

2.59

30.86

2.2

1.7

1.26

1.38

g/l

0.39

188

761

Chronic myeloid leukaemia [CML], BCR/ABL-positive

178

5.14

30.74

1.3

1.8

1.10

1.39

g/l

0.49

163

Viral warts

384

2062

1.95

30.56

2.3

1.8

1.48

1.36

g/l

0.32

361

1900

Dermatophytosis

471

2690

1.82

30.55

2.0

1.9

1.33

1.35

g/l

0.05

428

2445

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1419

6921

1.41

30.34

2.2

1.5

1.45

1.21

g/l

2.06

1262

6250

Triptan medication for migraine, min. 3 purchases

2000

11611

1.33

30.34

1.8

1.30

g/l

0.01

1871

10705

Injuries to the shoulder and upper arm

2908

18699

1.27

30.32

1.9

1.28

1.31

g/l

0.26

2623

17097

Viral infections of the central nervous system

309

1548

2.10

30.26

2.1

1.8

1.18

1.36

g/l

1.19

280

1429

Lichen simplex chronicus and prurigo

249

1150

2.29

30.25

2.0

1.8

1.28

1.32

g/l

0.12

223

1048

Injuries to the hip and thigh

1541

10255

1.38

30.20

1.8

1.9

1.33

1.34

g/l

0.10

1385

9278

Primary hyperparathyroidism

399

2179

1.91

30.16

1.9

1.8

1.25

1.40

g/l

0.86

358

1966

1223

7950

1.44

29.84

2.2

1.9

1.46

1.38

g/l

0.30

1099

7080

Cardiomyopathy (excluding other)

407

2236

1.88

29.84

1.6

1.9

1.21

1.42

g/l

1.10

381

2006

Type 1 diabetes, wide definition, subgroup 1

733

4703

1.60

29.80

1.7

1.9

1.23

1.36

g/l

1.49

667

4320

Cardiomyopathy, other and unspecified

279

1354

2.16

29.64

2.1

1.9

1.42

1.46

g/l

0.07

258

1229

Deviated nasal septum

1076

7477

1.47

29.58

1.9

1.22

1.33

g/l

0.96

983

6826

Allergic purpura

152

570

2.91

29.52

1.7

1.07

1.45

g/l

1.53

133

525

Hypertensive Renal Disease

142

510

2.96

29.49

1.9

2.0

1.25

1.82

g/l

1.18

129

456

Panic disorder

535

3197

1.72

29.25

1.7

1.8

1.25

1.31

g/l

0.62

492

2987

Fracture of shoulder and upper arm

1212

8625

1.43

29.17

1.9

1.32

1.34

g/l

0.09

1089

7840

Lung cancer and mesothelioma

480

2363

1.78

29.11

1.8

1.69

1.53

g/l

0.36

438

2082

Diseases of external ear

1148

8118

1.44

28.94

1.8

1.9

1.36

1.31

g/l

0.22

1013

7404

Viral infections of the central nervous system

287

1424

2.12

28.90

2.1

1.8

1.21

1.36

g/l

0.86

260

1313

Sacroiliitis, not elsewhere classified

204

884

2.45

28.85

1.6

1.9

1.28

1.44

g/l

1.12

198

826

Generalized anxiety disorder

567

3456

1.69

28.71

1.7

1.8

1.34

1.31

g/l

0.11

517

3223

Mature T/NK-cell lymphomas, hilmo

241

4.18

28.57

1.7

1.6

1.03

1.43

g/l

1.10

217

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

760

4406

1.57

28.54

1.6

1.8

1.23

g/l

0.01

707

4118

Disorders of continuity of bone

371

2017

1.92

28.44

2.2

1.8

1.28

1.35

g/l

0.28

334

1855

Alcohol dependence

886

5993

1.51

28.28

1.5

1.9

1.35

1.31

g/l

0.25

792

5487

Amputation of toe

263

1275

2.17

28.19

1.7

1.9

1.23

1.42

g/l

0.68

234

1154

Carpal tunnel syndrome

2036

13886

1.31

27.81

1.8

1.9

1.25

1.33

g/l

0.84

1862

12638

Unspecified chronic bronchitis

145

544

2.84

27.76

1.7

1.8

1.17

1.49

g/l

1.11

133

487

Poisoning by medicine

780

5165

1.55

27.72

1.6

1.8

1.33

1.31

g/l

0.13

706

4790

Myocardial infarction, without ST-elevation

1192

7774

1.42

27.54

1.8

1.9

1.24

1.39

g/l

1.15

1069

6957

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1019

7117

1.46

27.53

1.8

1.34

1.31

g/l

0.24

925

6595

Pyothorax

185

788

2.52

27.45

2.2

1.7

1.38

g/l

0.00

169

723

Acute gastritis

265

1299

2.13

27.42

1.8

1.9

1.37

1.41

g/l

0.11

241

1173

Mental and behavioural disorders due to opioids

180

758

2.55

27.41

1.5

1.8

1.61

1.21

g/l

3.43

171

700

Other enthesopathies

985

6840

1.47

27.39

1.9

1.45

1.36

g/l

0.40

892

6252

Nonorganic sleeping disorders

729

4776

1.57

27.28

1.7

1.9

1.29

1.31

g/l

0.11

669

4418

Stroke, excluding SAH

1893

10591

1.32

27.08

1.8

2.0

1.17

1.36

g/l

4.26

1691

9565

L01XE Protein kinase inhibitors

227

1061

2.29

27.08

3.3

1.8

1.95

1.48

g/l

0.77

200

972

KRA_PSY_EATING, excluding more controls

287

1444

2.05

27.04

1.6

1.8

1.17

1.40

g/l

3.21

264

1363

Other inflammation of eyelid

483

2875

1.74

27.03

2.2

1.8

1.36

1.35

g/l

0.01

439

2628

Oxicams

756

2775

1.58

26.95

1.9

1.23

1.41

g/l

1.03

674

2524

Cutaneous lupus erythematosus

123

434

3.12

26.94

1.7

1.9

1.39

1.56

g/l

0.38

112

396

Heartburn

364

1996

1.89

26.92

1.7

1.8

1.33

1.42

g/l

0.22

328

1822

Cerebral palsy and other paralytic syndromes

409

2329

1.82

26.84

2.0

1.9

1.39

1.36

g/l

0.06

376

2130

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1301

6458

1.40

26.84

2.3

1.5

1.53

1.21

g/l

2.60

1151

5818

Dentofacial anomalies [including malocclusion]

2449

15629

1.27

26.66

1.9

1.8

1.26

1.30

g/l

0.43

2257

14359

Use of anticholinesterases

402

5454

0.57

26.63

1.6

1.9

1.65

1.41

g/l

0.44

330

4803

N06DA Anticholinesterases

402

5454

0.57

26.63

1.6

1.9

1.65

1.41

g/l

0.44

330

4803

Other follicular disorders

288

1475

2.05

26.56

2.0

1.9

1.26

1.38

g/l

0.43

267

1382

Insomnia

3033

17962

1.24

26.49

1.6

1.9

1.32

1.31

g/l

0.09

2778

16441

Covid-19 suspected case

766

5108

1.54

26.32

2.1

1.8

1.45

1.30

g/l

0.61

718

4718

Actinic keratosis

1095

7217

1.43

26.24

2.3

1.9

1.48

1.38

g/l

0.40

979

6410

Familial hypercholesterolemia

460

2720

1.74

26.17

1.8

1.9

1.23

1.47

g/l

1.01

416

2431

Atopic dermatitis, strict definition

1062

7384

1.44

26.16

1.9

1.8

1.21

1.29

g/l

1.34

1001

6869

Other and unspecified disorders of skin and subcutaneous tissue

242

1171

2.18

26.13

2.2

1.8

1.30

1.45

g/l

0.57

202

1059

Personality disorders

943

6564

1.47

26.02

1.7

1.8

1.28

1.31

g/l

0.22

847

6096

Infections with a predominantly sexual mode of transmission

1054

7473

1.44

25.99

1.9

1.8

1.33

1.31

g/l

0.20

956

6931

Vitamin D deficiency

106

352

3.36

25.96

2.2

1.6

1.14

1.23

g/l

0.43

319

Decubitus ulcer and pressure area

219

1021

2.25

25.94

1.7

1.9

1.17

1.45

g/l

1.47

196

917

Valvular operations

431

2509

1.77

25.94

1.6

1.9

1.11

1.42

g/l

2.66

395

2251

Stroke, including SAH

2007

11311

1.30

25.91

1.8

2.0

1.16

1.36

g/l

4.66

1792

10223

Peripheral arterial reconstruction

510

3109

1.69

25.86

1.6

1.8

1.19

1.40

g/l

1.44

456

2748

Conductive and sensorineural hearing loss

2614

14129

1.26

25.84

2.0

1.9

1.34

1.31

g/l

0.19

2353

12866

Malignant neoplasm of skin

1436

7284

1.37

25.82

2.2

1.5

1.48

1.21

g/l

2.48

1270

6589

Injuries to the wrist and hand

3527

20204

1.22

25.80

1.8

1.9

1.26

1.31

g/l

0.93

3218

18494

Amenorrhoea

264

1322

2.08

25.79

2.1

1.8

1.39

1.40

g/l

0.04

243

1225

Other and unspecified myopathies

307

1622

1.98

25.75

1.8

1.9

1.17

1.40

g/l

1.42

276

1468

Skin changes due to chronic exposure to nonionizing radiation

1125

7445

1.42

25.73

2.2

1.9

1.47

1.39

g/l

0.30

1008

6622

Disorders of myoneural junction and muscle in diseases classified elsewhere

150

5.09

25.72

2.2

1.6

1.21

1.40

g/l

0.31

138

Allergic urticaria

317

1694

1.95

25.72

2.0

1.8

1.30

1.36

g/l

0.23

291

1562

Type 1 diabetes, wide definition

755

5041

1.53

25.60

1.7

1.9

1.23

1.35

g/l

1.43

689

4638

Acute lymphadenitis

243

1188

2.16

25.58

2.3

1.8

1.14

1.31

g/l

0.70

222

1108

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

572

3601

1.63

25.53

1.8

1.34

1.35

g/l

0.02

532

3317

Disorders of tooth development and eruption

560

2815

1.65

25.43

2.1

1.8

1.19

1.32

g/l

1.38

526

2572

Faecal incontinence

296

1549

1.98

25.40

2.0

1.8

1.34

1.48

g/l

0.35

258

1400

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1883

14219

1.31

25.32

1.9

1.8

1.32

1.30

g/l

0.15

1712

13046

Other obstetric conditions, not elsewhere classified

1063

4774

1.44

25.21

1.8

1.34

g/l

0.03

996

4451

Other symptoms and signs involving the urinary system

362

2028

1.85

25.15

2.0

1.9

1.16

1.38

g/l

0.78

344

1834

Abnormalities of gait and mobility

415

2420

1.78

25.13

1.8

1.9

1.23

1.39

g/l

1.11

369

2187

Other disorders of optic [2nd] nerve and visual pathways

254

1272

2.11

25.09

2.3

1.8

1.10

1.39

g/l

2.20

231

1165

Intestinal adhesions without obstruction

286

1487

2.00

25.09

2.0

1.8

1.17

1.44

g/l

1.47

262

1334

Benign neoplasm: Transverse colon

375

2131

1.83

24.96

2.0

1.9

1.21

1.41

g/l

1.26

344

1919

Seborrhoeic dermatitis

341

1882

1.89

24.94

2.0

1.9

1.44

1.31

g/l

0.39

303

1725

Radiculopathy

514

3173

1.66

24.80

1.9

1.37

1.41

g/l

0.10

473

2872

Colonic or urogenital fistula

900

6277

1.47

24.65

1.9

1.14

1.35

g/l

3.00

815

5752

Type of accident

988

7009

1.44

24.58

1.7

1.8

1.26

1.31

g/l

0.39

892

6430

Superficial injury of lower leg

847

5844

1.48

24.53

1.7

1.8

1.24

1.33

g/l

0.58

773

5334

Other local infections of skin and subcutaneous tissue

373

2126

1.82

24.51

2.1

1.9

1.23

1.37

g/l

0.47

346

1948

DVT of lower extremities

593

3799

1.60

24.51

2.3

1.9

1.32

1.39

g/l

0.27

530

3430

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1032

4632

1.44

24.34

1.8

1.34

1.35

g/l

0.07

970

4320

Iron deficiency

130

498

2.82

24.22

1.7

1.9

1.30

1.37

g/l

0.27

120

459

Alcohol abuse, main dg, excluding more controls

499

3079

1.67

24.19

1.6

1.9

1.31

1.30

g/l

0.02

462

2853

Other and unspecified local infections of skin and subcutaneous tissue

355

2004

1.84

24.14

2.1

1.9

1.24

1.36

g/l

0.34

330

1835

Spondylolisthesis/Spondylolysis

597

3846

1.59

24.12

1.9

1.8

1.38

g/l

0.00

540

3494

Other/unspecified reactive arthropathies

261

1339

2.05

24.09

1.9

1.8

1.27

1.32

g/l

0.18

246

1235

Hypopituitarism

298

1600

1.96

24.03

1.9

1.18

1.24

g/l

0.26

282

1493

Vascular diseases of the intestine

149

610

2.59

23.98

1.7

1.8

1.35

1.52

g/l

0.36

137

548

300

1614

1.94

23.83

1.3

1.9

1.82

1.37

g/l

2.47

265

1469

Acute bronchiolitis

268

1248

2.03

23.75

2.0

1.8

1.20

1.16

g/l

0.18

255

1164

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

168

4.58

23.73

3.2

1.7

1.60

1.52

g/l

0.06

151

Degeneration of macula and posterior pole

1392

8302

1.35

23.70

2.0

1.9

1.44

1.36

g/l

0.37

1245

7405

Umbilical hernia

886

6206

1.46

23.69

1.8

1.9

1.32

1.35

g/l

0.12

809

5690

Isolated proteinuria with specified morphological lesion

229

3.96

23.68

1.9

1.5

1.56

1.51

g/l

0.03

211

Emotional disorders starting during childhood or adolecense, excluding more controls

178

772

2.36

23.54

1.8

1.27

1.19

g/l

0.55

162

723

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

156

661

2.53

23.50

2.5

1.7

1.30

1.48

g/l

0.57

144

609

Fracture of foot, except ankle

839

5833

1.47

23.40

2.0

1.8

1.31

1.32

g/l

0.06

764

5383

Amputation of ankle bones

105

367

3.13

23.37

1.7

1.6

1.25

1.57

g/l

0.55

336

Oter anti-inflammatory and antirheumatic agents, non-steroids

690

2490

1.56

23.30

1.9

1.28

1.43

g/l

0.69

623

2258

Malignant neoplasm of digestive organs

1040

5889

1.42

23.27

1.8

1.5

1.39

1.19

g/l

1.39

941

5323

Other symptoms and signs involving cognitive functions and awareness

1429

9845

1.34

23.22

1.8

1.9

1.36

1.34

g/l

0.09

1273

8910

Arthropathy in ulcerative colitis

246

3.74

23.15

1.7

1.35

1.44

g/l

0.18

228

Hypocalcemia

118

444

2.93

23.07

2.4

1.7

1.23

1.53

g/l

0.87

103

410

Diseases of tongue

222

1091

2.13

22.95

2.1

1.8

1.37

1.40

g/l

0.05

201

979

Alzheimer disease, including avohilmo

464

5239

0.61

22.93

1.9

1.89

1.42

g/l

1.14

376

4627

Other diseases of gallbladder

168

741

2.40

22.91

1.8

1.55

1.58

g/l

0.04

159

669

Epilepsy

989

7081

1.42

22.80

1.8

1.9

1.30

1.33

g/l

0.21

896

6479

Disorders of adult personality and behaviour

976

7001

1.42

22.79

1.7

1.8

1.28

1.30

g/l

0.19

878

6511

Enthesopathies of lower limb, excluding foot

719

4877

1.51

22.75

1.8

1.19

1.36

g/l

2.31

646

4463

Speech and linguistic disorders, excluding more controls

304

1562

1.90

22.72

2.0

1.8

1.10

1.24

g/l

1.36

280

1460

Acute posthaemorrhagic anaemia

133

530

2.67

22.69

2.6

1.8

1.60

1.57

g/l

0.02

118

483

Unspecific neurodegenerative disorder

595

6165

0.65

22.65

1.8

1.9

1.84

1.40

g/l

1.33

493

5462

Viral warts

736

5025

1.50

22.64

2.2

1.8

1.38

1.31

g/l

0.28

680

4627

Pyoderma gangrenosum

152

4.74

22.62

2.2

1.6

1.11

1.39

g/l

0.59

140

Sensorineural hearing loss

2436

13350

1.25

22.57

2.0

1.9

1.36

1.32

g/l

0.30

2190

12147

Endometriosis

1114

4729

1.40

22.56

1.7

1.8

1.37

1.35

g/l

0.12

1004

4290

Disorders of porphyrin and bilirubin metabolism

221

3.89

22.53

1.8

1.7

1.11

1.54

g/l

0.72

200

Acute laryngitis and tracheitis

414

2440

1.72

22.46

2.0

1.7

1.22

1.30

g/l

0.55

384

2277

Ankylosing spondylitis, strict definition

192

906

2.25

22.39

1.5

1.9

1.20

1.30

g/l

0.59

184

849

Hydronephrosis

357

2059

1.79

22.38

1.8

1.15

1.44

g/l

2.22

335

1851

Bipolar affective disorders

633

4199

1.54

22.38

1.6

1.9

1.24

1.33

g/l

0.51

574

3898

Disturbance of activity and attention

443

2654

1.69

22.36

1.5

1.8

1.25

1.22

g/l

0.44

411

2481

Infections with a predominantly sexual mode of transmission

1333

9361

1.35

22.35

1.8

1.7

1.32

1.28

g/l

0.33

1202

8697

Myocardial infarction, strict

1336

7133

1.35

22.30

1.7

2.0

1.18

1.43

g/l

3.44

1215

6403

Nasal polyp

615

4065

1.55

22.15

1.8

1.9

1.23

1.40

g/l

1.22

564

3696

Mental and behavioural disorders due to tobacco

323

1822

1.85

22.14

1.7

1.8

1.24

1.35

g/l

0.45

295

1674

Benign neoplasm: Rectum, anus and anal canal

638

4254

1.54

22.11

2.0

1.8

1.55

1.37

g/l

0.63

586

3833

Vitamin B12 deficiency anaemia

323

1820

1.83

21.93

2.0

1.8

1.44

1.45

g/l

0.01

285

1632

Propionic acid derivatives

987

3513

1.43

21.91

1.9

1.41

1.35

g/l

0.27

902

3214

Other bursopathies

431

2633

1.69

21.85

2.2

2.0

1.19

1.47

g/l

1.17

391

2392

Allergic conjunctivitis

1954

15138

1.27

21.85

1.9

1.8

1.32

1.30

g/l

0.15

1780

13905

Benign neoplasm: Ascending colon

456

2833

1.66

21.75

2.0

1.9

1.47

1.38

g/l

0.26

423

2556

Smoking dependency

323

1834

1.84

21.67

1.7

1.8

1.24

1.35

g/l

0.46

295

1689

Ventral hernia

756

5232

1.48

21.63

1.8

1.9

1.35

g/l

0.01

689

4729

Other and unspecified psoriasis

250

1312

2.00

21.60

1.7

1.9

1.24

1.41

g/l

0.96

235

1207

Ischaemic Stroke, excluding all haemorrhages

1716

9967

1.30

21.58

1.8

2.0

1.14

1.37

g/l

5.53

1533

8991

Sub-endpoint used in defining T1D endpoints

961

6824

1.41

21.52

1.7

1.9

1.22

1.31

g/l

0.97

878

6235

Nonischemic cardiomyopathy

316

1780

1.84

21.51

1.9

1.29

1.40

g/l

0.33

293

1595

Bronchitis, not specified as acute or chronic

290

1593

1.89

21.51

1.8

1.9

1.23

1.38

g/l

0.69

265

1458

Bullous disorders

214

1066

2.11

21.49

1.8

1.26

1.43

g/l

0.60

201

967

Malnutrition

107

397

2.96

21.46

2.2

1.7

1.76

1.49

g/l

0.23

363

Migraine, single triptan purchase ok & required. ICD-code if available is included

2675

14853

1.23

21.46

1.8

1.28

1.30

g/l

0.23

2493

13629

Triptan medication for migraine, single purchase ok

2675

14853

1.23

21.46

1.8

1.28

1.30

g/l

0.23

2493

13629

Tubulo-interstitial nephritis, not specified as acute or chronic

227

1151

2.05

21.46

2.2

1.7

1.26

1.48

g/l

0.88

211

1035

Disorders of iron metabolism

316

3.27

21.44

1.4

1.7

0.98

1.36

g/l

2.12

291

Chronic myeloproliferative disease

238

3.66

21.42

1.7

1.8

1.61

1.35

g/l

0.32

209

Maternal care for other conditions predominantly related to pregnancy

698

4677

1.50

21.29

1.7

1.8

1.44

1.32

g/l

0.83

651

4344

Superficial injury of head

767

5337

1.47

21.26

1.7

1.8

1.26

1.32

g/l

0.38

708

4853

Other localized connective tissue disorders

338

3.12

21.18

2.2

1.8

1.46

1.39

g/l

0.10

308

Alzheimer’s disease, strict definition

257

3858

0.54

21.15

1.9

1.8

2.12

1.45

g/l

1.05

205

3402

Personal history of other diseases and conditions

403

2433

1.70

21.09

1.8

1.7

1.18

1.33

g/l

1.54

365

2267

Chorioretinal inflammation

130

535

2.62

21.00

2.1

1.8

1.26

1.56

g/l

0.73

118

489

Benign neoplasm: Rectum

574

3790

1.56

20.92

2.0

1.8

1.43

1.35

g/l

0.32

527

3423

Molar incisor enamel hypoplasia

178

809

2.28

20.88

2.7

1.8

1.00

1.09

g/l

0.82

171

766

Seborrhoeic keratosis

673

4588

1.50

20.86

2.6

1.9

1.36

g/l

0.03

607

4131

Otitis media, unspecified

409

2292

1.69

20.85

2.2

1.8

1.21

1.31

g/l

0.56

385

2144

Specific personality disorders

797

5610

1.45

20.83

1.6

1.8

1.32

1.31

g/l

0.02

718

5214

Anti-inflammatory and antirheumatic products, non-steroids

979

3513

1.42

20.79

1.8

1.9

1.38

1.35

g/l

0.10

899

3214

Disorders of vestibular function (Vertigo)

1472

11194

1.31

20.76

1.9

1.26

1.36

g/l

1.43

1332

10134

Psoriasis (vulgaris), strict definition

148

649

2.44

20.73

1.4

1.8

1.21

1.32

g/l

0.46

137

606

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

584

3879

1.55

20.68

1.7

1.8

1.40

1.30

g/l

0.65

526

3602

Benign neoplasm: Stomach

337

1963

1.78

20.67

1.8

1.9

1.53

1.41

g/l

0.27

307

1777

Malignant neoplasm, without specification of site, including Hilmo

147

638

2.41

20.63

2.2

1.3

1.43

1.20

g/l

0.52

132

577

Cardiac murmurs and other cardiac sounds

316

1781

1.81

20.63

1.8

1.9

1.12

1.29

g/l

1.92

290

1627

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

305

1727

1.83

20.60

1.8

1.47

1.36

g/l

0.30

279

1597

Asthma mixed form (mode), excluding more controls

159

714

2.31

20.54

1.7

1.32

1.37

g/l

0.12

151

643

Oesophagitis

192

934

2.15

20.50

1.6

1.8

1.06

1.42

g/l

2.07

175

843

In situ neoplasms

1163

8738

1.35

20.27

2.2

1.9

1.25

1.40

g/l

1.67

1055

7893

Disorders of vitreous body and globe

1596

12015

1.29

20.19

1.9

1.31

1.36

g/l

0.37

1426

10900

Fitting and adjustment of other devices

1014

6720

1.38

20.18

1.9

1.34

1.42

g/l

0.39

918

6015

Other diseases of arteries and capillaries

298

1687

1.83

20.10

1.8

1.9

1.21

1.43

g/l

1.13

276

1522

Fluid overload

8.34

20.01

2.9

1.6

2.72

1.12

g/l

0.63

Other sleep disorders

370

2225

1.71

20.01

1.9

2.0

1.16

1.40

g/l

1.97

338

2034

Other disorders of veins

1267

9598

1.33

19.99

1.8

1.36

1.35

g/l

0.08

1136

8713

Chronic iridocyclitis

193

953

2.13

19.93

2.0

1.8

1.32

1.47

g/l

0.48

183

877

Other or ill-defined heart diseases

194

957

2.11

19.89

1.4

1.9

1.34

1.41

g/l

0.15

176

873

Fenamates

475

2029

1.62

19.88

1.9

1.23

1.46

g/l

1.24

434

1851

Other disorders of bladder

376

2276

1.70

19.85

2.2

1.9

1.14

1.45

g/l

2.28

324

2048

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

254

1378

1.92

19.77

1.7

1.8

1.37

g/l

0.01

235

1294

Basal cell carcinoma, including avohilmo

1253

6524

1.34

19.77

2.3

1.5

1.55

1.21

g/l

2.56

1102

5881

Trochanteric bursitis

446

2820

1.62

19.69

1.8

1.9

1.39

1.43

g/l

0.13

404

2564

Caries of enamel

3075

18603

1.20

19.68

1.9

1.8

1.31

1.29

g/l

0.20

2808

17074

IgA nephropathy (IgA glomerulonephritis)

117

475

2.68

19.62

1.6

1.17

1.35

g/l

0.65

109

438

Spontaneous rupture of synovium and tendon

278

1557

1.85

19.47

2.2

1.9

1.29

1.43

g/l

0.52

257

1404

Abscess of anal and rectal regions

295

1681

1.82

19.46

1.7

1.9

1.24

1.36

g/l

0.60

273

1559

Disorders of vitreous body

1549

11745

1.29

19.41

1.9

1.31

1.36

g/l

0.28

1380

10656

Abnormal findings on diagnostic imaging of central nervous system

184

902

2.15

19.38

2.5

1.9

1.17

1.36

g/l

0.95

176

832

Procreative management

1176

7412

1.35

19.28

1.9

1.8

1.27

1.26

g/l

0.08

1091

6866

Benign neoplasm: Sigmoid colon

590

3987

1.52

19.25

1.9

1.35

1.38

g/l

0.11

544

3594

Abnormal involuntary movements

445

2834

1.62

19.15

1.9

1.29

1.37

g/l

0.21

408

2588

Diseases of inner ear

1703

13095

1.27

19.14

1.9

1.23

1.35

g/l

2.04

1538

11879

Hyperkinetic disorders

459

2880

1.60

19.14

1.5

1.8

1.24

1.22

g/l

0.31

427

2694

Postzoster neuralgia

250

3.35

18.93

2.9

1.5

1.38

1.47

g/l

0.08

219

Alzheimer disease

388

4529

0.62

18.91

1.9

1.80

1.41

g/l

0.84

308

4000

Delirium, not induced by alcohol and other psychoactive substances

361

2186

1.70

18.85

1.9

1.8

1.34

1.38

g/l

0.09

318

1948

Other female pelvic inflammatory diseases

523

3464

1.55

18.84

1.9

1.8

1.40

1.36

g/l

0.12

473

3169

Mental and behavioural disorders due to sedatives or hypnotics

257

1423

1.88

18.83

1.5

1.8

1.52

1.32

g/l

0.98

238

1311

Asthma mixed form (mode)

159

741

2.22

18.80

1.7

1.32

1.35

g/l

0.06

151

669

Hidradenitis suppurativa

151

695

2.30

18.78

1.5

1.8

1.15

1.34

g/l

1.15

134

650

Basal cell carcinoma

1187

6210

1.34

18.73

2.3

1.5

1.54

1.21

g/l

2.41

1044

5590

Disorders of refraction and accommodation

901

6577

1.39

18.62

2.0

1.8

1.34

1.29

g/l

0.28

827

6078

Dental pulpitis, including avohilmo

3170

17363

1.20

18.62

1.7

1.9

1.26

1.30

g/l

0.52

2928

15936

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

305

1782

1.78

18.54

1.8

1.9

1.47

1.36

g/l

0.30

279

1651

Other abnormal uterine and vaginal bleeding

719

3604

1.46

18.49

1.9

1.42

1.36

g/l

0.34

641

3250

Combinations of oral blood glucose lowering drugs

843

6120

1.40

18.46

1.4

2.0

1.01

1.40

g/l

14.02

760

5557

Chronic tubulo-interstitial nephritis

140

631

2.34

18.23

1.8

1.7

1.24

1.48

g/l

0.69

122

575

Unspecified urinary incontinence

295

1716

1.78

18.19

1.8

1.43

1.38

g/l

0.13

248

1547

Unspecified nephritic syndrome

107

432

2.69

18.16

2.0

1.6

1.25

1.51

g/l

0.51

100

396

Olecranon bursitis

219

1167

1.96

18.11

1.8

1.9

1.36

1.37

g/l

0.02

202

1057

Cardiac arrest

176

732

2.12

18.04

1.5

2.0

1.25

1.78

g/l

1.87

158

656

Crystal arthropathies, rheuma endpoint

267

3.16

18.01

1.5

1.9

1.39

1.35

g/l

0.03

243

Tonsillectomy and adenotomy

1953

10998

1.25

17.99

1.7

1.8

1.23

1.26

g/l

0.46

1818

10209

Other hearing loss

787

5543

1.41

17.99

2.2

1.8

1.46

1.38

g/l

0.26

698

4952

Unspecified privation

364

2247

1.67

17.91

2.0

1.9

1.25

1.39

g/l

0.72

337

2062

Drug-induced systemic lupus erythematosus

137

4.45

17.83

1.7

1.17

1.41

g/l

0.38

127

Other and unspecified haemorrhagic conditions

281

3.13

17.81

2.4

1.5

1.25

1.42

g/l

0.26

257

Infectious mononucleosis

304

1794

1.75

17.76

1.8

1.7

1.51

1.25

g/l

1.24

279

1673

Metatarsalgia

315

1877

1.73

17.74

2.0

1.8

1.54

1.47

g/l

0.18

283

1718

Postprocedural disorders of digestive system, not elsewhere classified

129

570

2.41

17.73

1.8

1.11

1.41

g/l

1.29

120

526

Scleritis and episcleritis

224

1213

1.93

17.67

1.8

1.08

1.43

g/l

3.21

204

1118

Superficial injury of hip and thigh

446

2895

1.58

17.54

1.8

1.33

1.39

g/l

0.16

403

2621

Other shoulder lesions

314

1875

1.73

17.53

1.8

1.9

1.43

1.41

g/l

0.05

289

1720

Other enthesopathy of foot (+metatarsalgia)

337

2050

1.69

17.53

1.9

1.53

1.44

g/l

0.22

305

1876

Artrosis, including avohilmo

2825

12957

1.20

17.48

1.7

1.9

1.36

1.31

g/l

0.42

2570

11848

Suicide or other Intentional self-harm

807

5874

1.40

17.45

1.6

1.8

1.35

1.31

g/l

0.24

727

5437

Endocrine disorders, other/unspecified

352

2.84

17.40

2.2

1.5

1.16

1.35

g/l

0.59

327

Osteopathy in diseases classified elsewhere

144

4.26

17.36

5.6

1.8

0.60

1.35

g/l

2.49

130

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

299

1758

1.74

17.31

2.3

1.4

1.62

1.14

g/l

1.46

263

1548

Otitis externa

721

5161

1.43

17.28

1.9

1.31

1.34

g/l

0.11

649

4745

Meningitis

189

976

2.03

17.27

2.1

1.8

1.35

1.37

g/l

0.03

172

898

Nummular dermatitis

268

1541

1.80

17.25

2.1

1.9

1.44

1.33

g/l

0.25

244

1405

Other specified/unspecified soft tissue disorders

166

817

2.12

17.22

2.0

1.8

1.05

1.55

g/l

3.56

158

737

Panniculitis, unspecified

187

3.67

17.22

2.1

1.7

1.29

1.58

g/l

0.44

167

Social phobias

293

1726

1.75

17.19

1.9

1.8

1.29

g/l

0.00

272

1611

Intrahepatic Cholestasis of Pregnancy (ICP)

254

1442

1.83

17.13

1.7

1.8

1.37

g/l

0.04

235

1352

Other/unspecified synovitis and tenosynovitis

369

2311

1.64

17.05

1.7

1.9

1.30

1.42

g/l

0.31

330

2108

Other disorders of eyelid

1309

9740

1.30

16.99

1.9

1.29

1.38

g/l

0.55

1184

8755

Essential (haemorrhagic) thrombocythaemia

132

599

2.33

16.98

2.0

1.4

1.38

1.21

g/l

0.46

116

546

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

287

2.99

16.96

1.7

1.3

1.31

1.11

g/l

0.34

265

Pulmonary eosinophilia, not elsewhere classified

204

3.50

16.93

1.8

1.7

1.11

1.62

g/l

0.79

182

Erythema multiforme

103

423

2.62

16.82

2.1

1.7

1.04

1.49

g/l

1.65

392

Alzheimer’s disease (Late onset)

240

3508

0.57

16.79

2.0

1.9

2.19

1.46

g/l

1.06

189

3075

Artificial opening status

191

999

2.00

16.79

2.2

1.8

1.12

1.44

g/l

1.81

176

909

Hypoplasia of dental enamel , including avohilmo

162

780

2.16

16.78

2.8

1.8

1.02

1.09

g/l

0.51

156

739

Persistent mood disorders

608

4245

1.46

16.73

1.7

1.8

1.36

g/l

0.00

540

3882

Vulvovaginal ulceration/inflammation in other diseases

210

1133

1.93

16.72

2.0

1.8

1.27

1.39

g/l

0.73

187

1051

Viral meningitis

149

716

2.20

16.70

1.9

1.8

1.24

1.27

g/l

0.13

137

665

Cervicobrachial syndrome

678

4829

1.43

16.66

1.8

1.9

1.43

1.39

g/l

0.09

626

4414

Bacterial, viral and other infectious agents

320

1950

1.70

16.65

2.1

1.8

1.21

1.29

g/l

0.46

288

1819

Other erythematous conditions

140

658

2.26

16.63

1.7

1.25

1.43

g/l

0.61

128

610

Cluster headache, strict

142

670

2.23

16.61

1.6

1.9

1.12

1.33

g/l

1.44

128

622

Benign neoplasm: Small intestine

157

773

2.15

16.55

1.9

1.8

1.26

1.56

g/l

1.26

146

707

Emotionally unstable personality disorder

421

2739

1.58

16.54

1.7

1.8

1.35

1.34

g/l

0.04

383

2554

Necrosis of pulp, including avohilmo

1902

15526

1.24

16.53

1.9

1.8

1.30

g/l

0.05

1751

14267

Prurigo nodularis

105

439

2.57

16.50

1.9

1.8

1.08

1.32

g/l

1.00

395

Fracture of femur

747

4900

1.40

16.46

1.8

1.34

1.36

g/l

0.09

659

4367

Chondropathies

511

3468

1.51

16.44

1.8

1.20

1.35

g/l

1.06

457

3216

Bacterial, viral and other infectious agents

303

1829

1.71

16.39

2.1

1.8

1.21

1.30

g/l

0.43

273

1705

Melanocytic naevi

942

7100

1.35

16.25

2.2

1.8

1.42

1.32

g/l

0.49

876

6525

Use of pramipexole

668

4772

1.43

16.23

1.9

1.29

1.35

g/l

0.31

603

4314

Presence of other devices

641

4520

1.44

16.22

1.6

1.9

1.33

1.46

g/l

0.44

596

4041

Thyrotoxicosis, other and/or unspecified

631

4463

1.44

16.21

1.7

1.9

1.19

1.38

g/l

2.15

577

4088

Hyperhidrosis

104

433

2.52

16.21

2.2

1.7

1.46

1.27

g/l

0.24

395

Tuberculosis, IBD comorbidity

214

1171

1.89

16.19

1.8

1.33

1.46

g/l

0.23

193

1044

Pain associated with micturition

373

2374

1.62

16.18

2.2

1.9

1.50

1.37

g/l

0.25

342

2170

Extreme obesity with alveolar hypoventilation

155

765

2.14

16.18

2.2

1.8

1.21

1.39

g/l

0.54

143

700

Arthropathy in Crohn disease

195

3.53

16.17

1.7

1.5

1.43

1.31

g/l

0.31

179

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

569

3830

1.47

16.17

1.8

1.9

1.21

1.28

g/l

0.47

548

3551

Other crystal arthropathies

284

2.96

16.16

1.5

1.8

1.39

1.70

g/l

0.33

257

Disorders of psychological development

429

2607

1.57

16.15

1.9

1.8

1.12

1.20

g/l

0.93

397

2425

Seronegative juvenile rheumatoid arthritis

378

2.70

16.14

1.9

1.31

1.34

g/l

0.08

348

Pneumonitis due to solids and liquids

248

1420

1.80

16.14

1.6

1.9

1.29

1.38

g/l

0.30

212

1284

Neuralgia and neuritis, unspecified

179

929

2.01

16.07

2.3

1.8

1.60

1.50

g/l

0.13

166

845

Charcot foot

297

2.92

16.04

1.9

1.64

1.76

g/l

0.09

269

Thiazolidinediones

344

2154

1.64

16.00

1.4

1.9

1.10

1.48

g/l

3.11

309

1924

Other noninflammatory disorders of vulva and perineum

301

1822

1.70

15.99

1.8

1.37

1.36

g/l

0.05

275

1661

Autoimmune hyperthyroidism

176

908

2.00

15.92

1.8

1.7

1.26

1.43

g/l

0.85

163

820

Respiratory conditions due to other external agents

351

2.74

15.85

2.6

1.6

1.26

1.52

g/l

0.32

316

Cervicocranial syndrome

339

2120

1.64

15.81

1.8

1.9

1.28

1.43

g/l

0.52

318

1926

Agoraphobia

129

598

2.27

15.78

2.0

1.7

1.21

1.31

g/l

0.54

117

559

Other disorders of glucose regulation and pancreatic internal secretion

285

1709

1.72

15.78

1.6

1.9

1.11

1.35

g/l

2.54

259

1571

Cluster headache, wide

147

717

2.15

15.77

1.6

1.9

1.10

1.39

g/l

1.63

133

661

Acute alcohol intoxication, ICD10

644

4596

1.43

15.75

1.6

1.9

1.32

1.31

g/l

0.10

583

4244

Gingival hyperplasia

150

741

2.15

15.74

2.6

1.8

1.34

g/l

0.00

136

688

Paralytic ileus

129

598

2.26

15.72

1.8

1.7

1.31

1.61

g/l

0.78

121

539

Juvenile rheumatoid arthirtis

387

2.62

15.71

2.3

1.7

1.19

1.38

g/l

0.83

358

778

4974

1.38

15.60

1.9

1.48

1.39

g/l

0.32

689

4395

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

594

4064

1.45

15.58

1.8

1.9

1.20

1.27

g/l

0.58

571

3763

Vitreous haemorrhage

325

2022

1.66

15.58

1.7

2.0

1.08

1.39

g/l

3.22

279

1838

Iridocyclitis in diseases classified elsewhere

355

2.72

15.54

2.0

1.7

1.17

1.61

g/l

1.21

327

Mixed hyperlipidaemia

142

688

2.17

15.50

1.4

1.9

1.06

1.53

g/l

2.64

127

624

Other bacterial agents as the cause of diseases classified to other chapters

190

3.50

15.46

2.7

1.7

1.49

1.75

g/l

0.21

172

Malignant neoplasm of other and unspecified parts of biliary tract

188

3.40

15.44

1.6

1.3

1.50

1.11

g/l

0.55

176

Benign neoplasm of other and unspecified endocrine glands

427

2835

1.55

15.38

1.6

1.9

1.16

1.36

g/l

1.55

388

2586

Infective dermatitis

355

2262

1.61

15.34

1.8

1.9

1.36

1.31

g/l

0.18

324

2053

Noninflammatory disorders of female genital tract

1314

5159

1.29

15.34

1.8

1.34

1.35

g/l

0.03

1198

4690

Corneal ulcer

589

4161

1.45

15.30

1.8

1.17

1.32

g/l

1.81

544

3827

Monoarthritis, not elsewhere classified

145

711

2.13

15.28

1.5

1.9

1.43

1.48

g/l

0.11

136

646

Excessive attrition of teeth

1831

15061

1.23

15.25

1.8

1.34

1.30

g/l

0.20

1695

13821

Other disorders of nervous system

228

1301

1.82

15.21

2.6

1.9

1.65

1.43

g/l

0.29

202

1185

Adult respiratory distress syndrome

212

3.27

15.18

2.0

1.6

0.89

1.65

g/l

1.47

194

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

256

1510

1.76

15.14

1.5

1.8

1.59

1.24

g/l

3.11

236

1402

Diabetic neuropathy

388

2524

1.58

15.14

1.7

1.19

1.21

g/l

0.06

353

2296

Diseases of male genital organs

1655

6732

1.25

15.01

1.8

1.9

1.17

1.24

g/l

0.58

1530

6180

Mouth breathing

1277

10114

1.28

14.98

1.7

1.9

1.26

1.30

g/l

0.22

1164

9296

Other epidermal thickening

159

814

2.05

14.97

1.9

1.7

1.20

1.41

g/l

0.59

148

744

Primary adrenocortical insufficiency

215

3.28

14.96

2.0

1.7

1.23

1.35

g/l

0.24

201

Fracture of lower leg, including ankle

1750

14207

1.23

14.94

1.8

1.9

1.25

1.31

g/l

0.85

1616

12944

Alcohol-induced chronic pancreatitis

225

1287

1.82

14.93

1.5

1.9

1.24

1.38

g/l

0.67

209

1196

Polycythaemia vera

111

495

2.36

14.91

1.8

1.3

1.69

1.21

g/l

1.22

445

Leisure time condition

575

4068

1.44

14.84

1.8

1.25

1.32

g/l

0.39

514

3733

Injuries to the neck

729

5366

1.38

14.80

1.9

1.8

1.35

1.33

g/l

0.07

670

4930

Use of memantine

321

4170

0.63

14.78

1.9

2.25

1.43

g/l

1.46

247

3676

Use of other anti-dementia drugs

321

4170

0.63

14.78

1.9

2.25

1.43

g/l

1.46

247

3676

Pleural plaque

266

1593

1.72

14.76

1.7

1.9

1.19

1.46

g/l

0.70

236

1415

Atypical facial pain

181

972

1.94

14.75

2.3

1.7

1.65

1.37

g/l

0.39

167

881

Cluster headache, strict, including avohilmo

186

1009

1.93

14.72

1.6

1.8

1.12

1.35

g/l

2.14

171

938

Traumatic subdural haemorrhage

358

2207

1.59

14.71

1.7

1.9

1.61

1.41

g/l

0.47

307

1977

Otalgia

270

1633

1.71

14.56

1.9

1.8

1.35

g/l

0.00

246

1503

Other disorders starting during childhood or adolecense, excluding more controls

177

904

1.95

14.53

1.9

1.8

1.18

1.15

g/l

0.09

169

851

Benign neoplasm: Duodenum

108

485

2.39

14.52

2.0

1.7

1.33

1.52

g/l

0.42

102

444

Use of donepezil

210

3464

0.57

14.48

1.7

1.9

1.57

1.49

g/l

0.09

168

3040

Sequelae of cerebrovascular disease

995

6608

1.32

14.41

1.7

1.9

1.22

1.44

g/l

2.62

886

5916

Pneumothorax

217

1239

1.81

14.38

1.9

1.8

1.15

1.43

g/l

1.80

202

1128

Other specific arthropathies, wide

331

2.67

14.36

1.9

1.8

1.13

1.39

g/l

1.04

305

Other and unspecified visual disturbances

330

2103

1.62

14.35

2.0

1.8

1.51

1.41

g/l

0.25

304

1916

Other disorders of conjunctiva

431

2908

1.52

14.35

1.8

1.9

1.16

1.39

g/l

2.25

397

2624

Benign paroxysmal vertigo

873

6632

1.34

14.34

2.0

1.9

1.27

1.38

g/l

0.97

798

6021

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

238

1403

1.76

14.15

1.8

1.39

1.34

g/l

0.12

220

1301

Other disorders of the musculoskeletal system and connective tissue

458

3139

1.49

14.11

1.9

1.33

1.38

g/l

0.15

420

2866

Speech therapy

803

6045

1.35

14.08

1.9

1.34

1.35

g/l

0.02

757

5493

Other meningitis

325

2.72

14.05

2.1

1.7

1.65

1.41

g/l

0.17

300

Impetigo

175

946

1.94

14.04

2.3

1.8

1.53

1.35

g/l

0.32

167

883

Heart failure and hypertrophic cardiomyopathy

319

2.72

14.03

1.8

1.6

1.50

1.53

g/l

0.02

290

Superficial injury of abdomen, lower back and pelvis

475

3281

1.48

13.99

1.9

1.26

1.34

g/l

0.46

430

3002

Other keratitis

369

2425

1.56

13.97

1.9

1.8

1.21

1.38

g/l

1.54

342

2234

Cystic fibrosis with pulmonary manifestations

18.90

13.90

3.5

2.5

1.22

1.27

g/l

0.06

Inflammatory disease of uterus

437

2975

1.50

13.89

1.8

1.38

1.35

g/l

0.08

392

2741

Tuberculosis, wide

217

1251

1.79

13.87

1.8

1.32

1.47

g/l

0.27

196

1112

Visual impairment including blindness (binocular or monocular)

215

1238

1.80

13.86

1.9

1.8

1.16

1.48

g/l

1.44

184

1120

Cluster headache, wide,, including avohilmo

191

1065

1.87

13.85

1.6

1.8

1.11

1.39

g/l

2.21

176

990

Dermatophytosis

1927

16060

1.21

13.85

1.8

1.9

1.32

1.31

g/l

0.04

1765

14701

Other predominantly sexually transmitted diseases, not elsewhere classified

554

3944

1.43

13.83

1.9

1.8

1.32

1.31

g/l

0.06

499

3663

Unspecified/other endometriosis

287

1782

1.65

13.83

1.8

1.22

1.36

g/l

1.65

266

1640

Carcinoma in situ of skin

259

1571

1.70

13.82

2.2

1.9

0.95

1.51

g/l

7.75

236

1405

Malignant neoplasm, without specification of site

390

2.46

13.81

2.6

1.3

1.58

1.17

g/l

0.63

354

Scleritis

236

3.02

13.74

1.8

1.7

1.06

1.32

g/l

0.92

221

Other bacterial agents as the cause of diseases classified to other chapters

237

3.03

13.69

2.7

1.7

1.47

1.64

g/l

0.15

216

Unspecified misadventure during surgical and medical care

193

1084

1.86

13.69

2.0

1.8

1.36

1.46

g/l

0.25

179

992

Erosion of teeth , including avohilmo

797

6023

1.35

13.63

1.8

1.24

1.32

g/l

0.55

729

5571

Nonspecific lymphadenitis

208

1195

1.81

13.59

2.1

1.8

1.16

1.33

g/l

0.61

192

1109

Other blood glucose lowering drugs, excl. Insulins

457

3151

1.48

13.59

1.6

1.9

1.20

1.47

g/l

1.61

425

2818

Malignant neoplasm of other connective and soft tissue, including Hilmo

134

668

2.10

13.58

2.2

1.4

0.96

1.17

g/l

1.26

123

612

Other endocrine disorders

216

1204

1.80

13.54

2.4

1.8

1.10

1.19

g/l

0.61

203

1127

Other extrapyramidal and movement disorders in other diseases

707

5258

1.37

13.49

1.8

1.9

1.37

1.36

g/l

0.02

637

4770

Open wound of ankle and foot

341

2221

1.58

13.48

1.8

1.19

1.37

g/l

1.08

308

2044

Other and unspecified erythematous conditions

123

599

2.17

13.43

1.7

1.20

1.45

g/l

0.89

112

554

Diabetic retinopathy

1123

5507

1.29

13.41

1.6

1.7

1.14

1.26

g/l

1.64

1008

4983

Other eating disorders

182

1008

1.87

13.40

1.7

1.8

1.19

1.38

g/l

1.85

166

943

Striking against or struck by other objects

1068

8398

1.29

13.39

1.8

1.9

1.38

1.27

g/l

0.76

958

7752

Barrett oesophagus

160

853

1.96

13.37

1.5

1.9

1.24

1.45

g/l

0.66

146

778

Degenerative diseases of the nervous system

510

5274

0.70

13.36

1.9

1.83

1.41

g/l

1.34

422

4668

Congenital malformations of the respiratory system

414

2.46

13.34

1.7

1.9

0.92

1.38

g/l

1.84

386

Superficial injury of wrist and hand

656

4833

1.38

13.31

1.8

1.9

1.34

1.30

g/l

0.12

608

4474

Nail disorders

274

1703

1.66

13.29

1.8

1.9

1.35

1.33

g/l

0.04

246

1561

Protein-energy malnutrition of moderate and mild degree

171

3.43

13.23

2.2

1.8

1.55

1.14

g/l

0.93

153

Insulin, fast-acting (human)

443

3056

1.48

13.15

1.6

1.9

1.20

1.37

g/l

2.04

400

2812

Acne

336

2188

1.57

13.15

1.6

1.7

1.24

1.29

g/l

0.33

307

2036

Otitis externa, unspecified

361

2398

1.55

13.05

2.0

1.8

1.34

1.38

g/l

0.11

335

2214

Injuries to the elbow and forearm

2295

17159

1.19

13.02

1.8

1.9

1.29

1.31

g/l

0.20

2086

15688

Acquired pure red cell aplasia [erythroblastopenia]

5.32

12.97

2.1

1.7

1.02

1.16

g/l

0.28

Localized scleroderma [morphea]

255

2.85

12.92

1.7

1.38

1.43

g/l

0.07

234

Disorders of orbit

158

851

1.94

12.86

1.9

1.7

1.31

1.40

g/l

0.17

145

783

Scoliosis

271

1692

1.65

12.85

1.9

1.8

1.14

1.44

g/l

2.87

252

1556

Presbycusis

349

2282

1.54

12.80

2.3

1.8

1.67

1.39

g/l

0.54

299

2000

Aortic aneurysm

611

4388

1.39

12.80

2.1

1.9

1.14

1.43

g/l

2.65

551

3911

Erythema nodosum

112

536

2.21

12.79

2.2

1.7

1.03

1.42

g/l

1.86

102

492

Alcohol abuse, main dg

499

3542

1.44

12.75

1.6

1.9

1.31

g/l

0.03

462

3278

Anosmia

218

2.88

12.74

1.5

1.6

1.04

1.40

g/l

1.57

202

Ulcer of oesophagus

198

1142

1.79

12.71

1.9

2.0

1.46

1.50

g/l

0.08

177

1024

Acidosis

365

2.49

12.68

1.6

1.8

1.22

1.58

g/l

0.78

335

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1840

12175

1.21

12.66

1.8

1.28

1.35

g/l

1.08

1700

11129

Collapsed vertebra, not elsewhere classified

119

3.85

12.61

3.8

2.0

0.92

1.97

g/l

1.08

109

Congenital malformations of trachea and bronchus

187

3.24

12.59

1.7

1.9

0.96

1.31

g/l

1.22

176

Other predominantly sexually transmitted diseases, not elsewhere classified

653

4851

1.37

12.57

1.9

1.8

1.30

1.29

g/l

0.04

585

4518

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1208

9672

1.26

12.55

1.8

1.38

1.28

g/l

0.74

1115

8962

Eating disorder

287

1826

1.61

12.49

1.6

1.7

1.17

1.38

g/l

3.15

264

1709

Use of amantadine

307

2.64

12.49

3.0

1.7

0.91

1.55

g/l

2.01

279

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

252

1560

1.67

12.48

1.8

1.42

1.44

g/l

0.07

232

1414

Familial hypercholesterolemia, with ischemic heart disease

260

1620

1.65

12.45

1.5

1.9

1.40

1.49

g/l

0.15

235

1418

Algoneurodystrophy

123

616

2.10

12.43

1.8

1.7

1.33

1.34

g/l

0.04

116

576

Thyrotoxicosis

764

5819

1.33

12.40

1.7

1.9

1.20

1.36

g/l

1.91

702

5305

Strabismus

839

6456

1.32

12.39

1.9

1.8

1.24

1.31

g/l

0.68

787

5935

Speech and linguistic disorders

324

2042

1.57

12.35

2.1

1.8

1.09

1.19

g/l

1.08

298

1907

Congenital malformations of the respiratory system

384

2.46

12.35

1.7

1.9

0.91

1.34

g/l

1.60

360

Chondrocostal junction syndrome [Tietze]

136

708

2.01

12.31

1.7

1.8

1.18

1.39

g/l

1.27

119

647

Thyroiditis

237

1451

1.69

12.29

1.8

1.29

1.42

g/l

0.49

214

1329

Personal history of allergy to drugs, medicaments and biological substances

205

3.04

12.28

2.2

1.8

1.11

1.32

g/l

0.52

190

Corns and callosities

209

1238

1.75

12.26

1.8

1.16

1.36

g/l

1.02

193

1122

Episcleritis

181

1034

1.82

12.15

1.9

1.7

1.06

1.36

g/l

2.58

164

958

Benign neoplasm: Liver/bile ducts

103

488

2.24

12.14

2.1

1.7

1.18

1.49

g/l

1.15

449

Carcinoma in situ of skin of other and unspecified parts of face

231

1409

1.69

12.08

2.3

1.8

1.00

1.53

g/l

3.83

205

1243

Emotional disorders and disorders of social functioning with onset specific to childhood

193

1105

1.78

12.04

1.8

1.9

1.26

1.19

g/l

0.42

176

1028

Other bullous disorders

108

523

2.19

12.04

1.9

1.8

1.21

1.50

g/l

0.83

102

484

Combined immunodeficiencies

191

3.11

12.04

4.2

1.6

1.29

1.77

g/l

0.58

174

Hallux valgus (acquired)

921

5160

1.30

11.96

1.8

1.38

1.39

g/l

0.04

825

4663

Calculus of kidney and ureter

875

6820

1.30

11.94

1.9

1.21

1.36

g/l

1.09

800

6204

Lesion of lateral popliteal nerve

165

926

1.85

11.77

2.1

1.7

1.18

1.27

g/l

0.30

148

849

Lichen planus

383

2631

1.49

11.77

1.6

1.8

1.29

1.38

g/l

0.42

348

2388

Fibroblastic disorders

641

4795

1.36

11.76

1.8

2.0

1.32

1.42

g/l

0.36

585

4324

Adhesive capsulitis of shoulder

481

3440

1.42

11.76

1.6

1.9

1.28

1.41

g/l

0.55

442

3130

Abscess of lung

298

2.61

11.76

2.7

1.6

1.31

1.61

g/l

0.51

274

Abnormal blood-pressure reading, without diagnosis

144

774

1.93

11.74

2.2

1.8

1.09

1.40

g/l

2.70

127

697

Squamous cell neoplasms and carcinomas of the skin

190

1105

1.76

11.73

2.4

1.4

1.70

1.13

g/l

1.17

168

974

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

255

1583

1.64

11.72

2.1

1.8

1.24

1.23

g/l

0.03

239

1496

Malignant neoplasm of small intestine, including Hilmo

461

2.23

11.68

1.7

1.3

1.25

1.17

g/l

0.12

421

Other disorders of patella

493

3543

1.42

11.67

1.7

1.9

1.26

1.36

g/l

0.51

441

3253

Benign neoplasm of mouth and pharynx

336

2254

1.53

11.66

2.3

1.8

1.62

1.38

g/l

0.49

304

2049

Childhood allergy (age < 16)

482

2836

1.43

11.59

1.7

1.22

1.21

g/l

0.09

445

2641

Anogenital herpesviral [herpes simplex] infection

206

1235

1.72

11.58

2.0

1.8

1.30

1.33

g/l

0.10

190

1153

Specific development disorders of scholastic skills

174

984

1.82

11.58

2.2

1.8

1.11

1.13

g/l

0.14

158

921

Dementia

729

6547

0.76

11.55

1.8

1.9

1.76

1.41

g/l

1.28

618

5833

Left ventricular outflow tract obstruction (LVOTO), broad definition

335

2254

1.53

11.51

1.7

1.9

1.14

1.24

g/l

0.62

309

2099

Speech disturbances, not elsewhere classified

263

1677

1.61

11.50

1.8

1.9

1.35

1.42

g/l

0.18

231

1516

Malignant neoplasm of mesothelium and soft tissue

118

598

2.05

11.48

2.2

1.4

1.02

1.18

g/l

0.70

111

547

Chronic conjunctivitis

116

587

2.08

11.47

1.8

1.05

1.30

g/l

1.64

108

544

Retinal detachments and breaks

1000

7964

1.27

11.43

2.0

1.9

1.44

1.35

g/l

0.43

916

7191

Open wound of wrist and hand

1395

11244

1.23

11.42

1.8

1.9

1.29

1.28

g/l

0.04

1275

10341

Fall on same level involving ice and snow

1778

15002

1.20

11.40

1.8

1.9

1.31

1.32

g/l

0.04

1620

13675

Alcohol-induced acute pancreatitis

132

701

1.98

11.33

1.7

1.8

1.10

1.42

g/l

1.68

121

653

Urolithiasis

931

7365

1.28

11.29

1.9

1.19

1.36

g/l

1.38

846

6697

Superficial injury of thorax

446

3174

1.43

11.27

1.7

1.9

1.40

1.35

g/l

0.21

412

2893

Acute nasopharyngitis (common cold)

350

2364

1.50

11.26

2.1

1.7

1.06

1.26

g/l

2.46

318

2201

Use of rivastigmine

145

2562

0.55

11.26

1.5

1.8

1.55

1.46

g/l

0.10

120

2236

Other condition

451

3219

1.43

11.25

1.7

1.8

1.32

1.33

g/l

0.02

415

2962

Status epilepticus

121

625

2.02

11.18

1.7

1.9

1.37

1.38

g/l

0.02

111

572

Malignant neoplasm of small intestine

322

2.47

11.17

1.9

1.3

1.32

1.16

g/l

0.19

297

Alcohol withdrawal state with delirium

223

1379

1.67

11.17

1.3

1.8

1.56

1.37

g/l

0.59

198

1275

Trigeminal neuralgia

184

1081

1.76

11.17

1.9

1.7

1.13

1.37

g/l

1.11

170

974

Bell's palsy

352

2403

1.50

11.17

2.2

1.9

1.59

1.35

g/l

0.61

328

2186

Acute alcohol intoxication

755

5826

1.31

11.16

1.6

1.9

1.27

1.31

g/l

0.33

677

5333

Non-allergic asthma

279

1816

1.58

11.15

2.1

1.9

1.41

1.35

g/l

0.13

267

1660

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

256

1632

1.60

11.14

2.2

1.4

1.66

1.14

g/l

1.35

234

1471

Tongue abnormality

197

1182

1.73

11.13

2.1

1.8

1.26

1.46

g/l

0.67

179

1072

Assault

430

3051

1.44

11.09

1.4

1.8

1.44

1.27

g/l

1.11

393

2844

533

3675

1.38

11.06

1.7

1.9

1.25

1.45

g/l

1.18

468

3225

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgM [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS